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Abstract
Tremor is the most common movement disorder met in clinical practice. Tremor is 
defined as an involuntary, rhythmic oscillation of a body region. Not all tremors are 
pathological. Tremor often causes occupational disability. It can affect the head and 
lower limbs but it mainly affects the upper limbs. Tremor is an interesting 
physiological phenomenon, which is present in all living organisms. It can also seen 
as a symptom of underlying dysfunction of the nervous system.
At first sight tremor looks simple but in fact it is a most complex physiological 
phenomenon. There are a number of different types of tremor, which are often 
confused with one another. This presents a practical problem for differential 
diagnosis and clinical management. Currently, tremor can be classified into rest and 
action tremors. Action tremors can be subdivided into postural, kinetic, intention 
and task specific types. Accurate diagnosis of tremor is important to both patient 
and clinician because the assessment of prognosis and the selection of treatment 
depend on the type of tremor. Electromyography and accelerometry are reliable and 
convenient techniques that are widely employed in the study of tremor. They have 
been used to measure tremor frequency, amplitude and other characteristics. The 
amplitude of most tremors is very variable. In contrast, the frequency of tremor is 
quite stable.
The underlying causes of tremor have been investigated by many authors but the 
mechanisms causing tremors remain unclear. However, the precise mechanisms of
tremor generation are not so important in this project. The principal question raised 
in this project was: does topical anaesthesia have a significant action on tremor 
amplitude?
Pozos and laizzo (1992) investigated the effect topical anaesthesia on essential 
tremor of the hand. In an earlier study Pozos and Mills (1985) investigated the 
effect of topical anaesthesia on clonus, resting physiological tremor and 
physiological action tremor of the ankle joint. Both of these studies reported 
significant decrease in tremor amplitude after the application of topical anaesthesia. 
In contrast, the data presented in this thesis cleaiiy show that there was no 
significant effect by either the placebo or topical anaesthesia on the magnitude of 
postural tremors, during movement or in a small number of case studies.
The effects of topical anaesthesia or a placebo spray on hand tremor were 
investigated in a total of 37 volunteers. Postural tremor was studied in 19 subjects. 
Movement tremor was studied in 12 subjects. Six cases pathological tremor were 
also investigated. The volunteers were blinded to the nature of the spray, which had 
been applied to their skin of the upper limb. Hand tremors were recorded by using a 
two-axis accelerometer (ADXL210E Analog Devices) that was attached to the 
middle finger of right hand. Electromyogram recordings were made from flexor and 
extensor muscle groups of forearm at the same time. The tremor acceleration and 
electromyography were recorded, digitised and stored on PC.
Subsequently, the power spectrum of the tremor was calculated. The tremor energy 
in four bands, 2-6 Hz, 6-12 Hz, and 12-20 Hz and the total band 2-20 Hz were 
studied. The electromyogram was filtered and its root mean square value was
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calculated. A Bland Altman analysis was employed to investigate the mean 
difference of the signals after application of a topical anaesthetic or placebo spray. 
The confidence interval of the mean difference was calculated. If the confidence 
interval did not contain zero, the difference was statistically significant.
In all these band frequencies studied no significant difference was found between 
the tremor after application of xylocaine and placebo sprays. The results of these 
studies are that skin anaesthesia did not change tremor amplitude. It is concluded 
that topical anaesthesia is not likely to be useful as a tool for the clinical 
management of tremor.
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Chapter 1
General Introduction and Literature Review
1.1 Introduction
Tremor is known to be the most common of ail movement disorders (Britton, 1995) 
and it has been given different interpretations by clinicians since ancient times. Galen 
described tremor in the second century. He described tremor as: “Voluntary 
movements caused by weakness of the force that supports and moves the body” 
(Zesiewicz and Hauser, 2001). Pratensis (1549) described a postural tremor as 
‘voluntary’ movement resulting from opposing muscle actions.
Tremors are defined in the current clinical literature as involuntary, rhythmic and 
oscillatory movements of body parts. Tremor may affect the head, face, jaw, voice, 
tongue, trunk or extremities. It may affect the quality of life by causing physical 
disability, such as impairment of the ability to work or daily living activities or 
recreational activities (Velickovic and Gracies, 2002). There are a number of 
different types of tremors, which are often confused with one another. Differentiation 
of tremors on clinical grounds is also difficult, for example, essential tremor is often 
misdiagnosed as Parkinson tremor (Rajput, 1995)
In 1904 Holmes reported that the tremor frequency is different in different types of 
diseases. Tremor frequency is often used to aid in the diagnosis of neurological 
disease. Indeed the selection of treatment type is often dependent on the tremor type.
Tremor research has developed rapidly in the past few years because clinicians and 
neuroscientists have become more interested in the oscillatory phenomena occurring 
under normal and abnormal conditions. The tremor frequency, amplitude, burst 
duration and patterns are commonly evaluated using electromyography (EMG) 
(Milanov, 2001). The tremor amplitude is often variable and depends on several 
physiological and emotional factors. Tremor frequency is usually a relatively 
constant feature, although fluctuations can occur (Cleeves and Findley, 1987; 
Deuschl, Krack, Lauk and Timmer, 1996; Freund, Honberg and Hefter, 1987; Gresty 
and Buckwell, 1990). The frequency ranges of different types of tremors overlap on 
range 3-12 Hz (Deuschl, Zimmermann, Gender and Lucking 1995; Findley and 
Cleeves, 1989).
1.2. Neurophysiology of tremor
Quantitative studies of tremor have been promoted by the development of 
neurophysiological techniques and accelerometers capable of recording tremor 
movement. This has allowed features such as tremor frequency, amplitude and other 
physiological characteristics to be investigated. It remains a matter of debate if 
accelerometric or electromyographic analysis is superior for the evaluation of tremor 
(Milanov, 2001). However, electromyography allows detection of the pattern of 
muscle activation, which may be useful (Milanov, 2001).
The pattern of muscle activation has been studied extensively with surfaee and 
needle EMG. Since EMG measures motor neuron activity indirectly, it provides 
information about the central nervous system commands, which generate the 
oscillatory movements. The temporal relationship of antagonistic muscle activity as
well as the modulation of motor units firing can also be obtained from EMG 
recordings (Lou and Jankovic, 1991).
Tremor of limb segments is known to be the result of complex interactions between 
the mechanical properties of the limb and the synchronisation of motor units firing. 
This involves peripheral reflex mechanism and central oscillators. (Lou and 
Jankovic, 1991). This is shown diagrammatically in figure 1.1. The mechanical 
properties of a limb determine the frequency and amplitude of tremor. The muscle, 
bones and other soft tissue of a limb comprise a mechanical system that is analogous 
to a mass attached to a set of springs. Such a system has a natural frequency at which 
it oscillates when a force is applied (Lou and Jankovic, 1991).
Central neural oscillators may also generate tremor (Lou and Jankovic, 1991). Two 
major pathological tremors, Parkinsonian tremor and cerebellar kinetic tremor, are 
associated with identifiable lesions in the central nervous system involving either the 
nigrostriatal system or the dentate nucleus. Three interconnecting neuronal loops in 
the central nervous system have been identified as potential generators of oscillations 
or tremors (Lee and Stein, 1981). One loop, involving basal ganglia, thalamus and 
cortex generates tremor in Parkinson’s disease possibly due to some modulating 
effect which the nigrostriatal dopaminergic system normally exerts on striatal 
neurones. Another loop that seems to be capable of generating tremor involves the 
cerebellum, red nucleus and inferior olive. Cerebellar tremor, rubral tremor and 
palatal myoclonus are associated with lesions in this system. Oscillation in the third 
loop involving the spinal cord and muscle receptors results in physiological tremor 
and enhanced physiological tremor.
In summary, the literature suggests that both central oscillators and peripheral 
mechanisms play an important role in the genesis of most tremors.
1.3. Classification of tremor
Tremors may be classified by three features (1) its appearance in limb segments 
during a maintained posture or during movement, (2) its aetiology, such as 
Parkinsonian or dystonie tremor, (3) by mechanical characteristics such as tremor 
frequency (Findley and Ko Her, 1994).
1.3.1. Classification of tremor by appearance
Resting tremor is described as an involuntary, rhythmic oscillation of a body part that 
is supported against gravity. It may be evident in the upper extremities such as when 
the patient’s hands are resting in the lab or hanging freely during walking. The 
frequency of rest tremor usually ranges from 3 to 6 Hz. Parkinson’s disease is the 
most common pathological cause of resting tremor (Zesiewicz and Hauser, 2001).
Action tremor occurs during voluntary contraction of skeletal muscles. It may be 
divided into postural, isometric and kinetic tremors (Velickovic and Gracies, 2002). 
Postural tremor occurs when the affected body part maintains a position against 
gravity such as holding arms outstretched in front of the body. Physiological tremor 
is the most common form. It is usually not visible to the eye, but it becomes obvious 
when using a laser pointer on a distant screen. Kinetic tremor occurs during 
voluntary movement. An example is cerebellar tremor, which becomes evident when 
a patient performs a finger-to-nose test or during daily living activities e.g. drinking 
or eating. Kinetic tremor may be further classified as simple or intention tremor.
Simple kinetic tremor occurs during movement of extremities, such as flexion- 
extension movement of the wrist. Intention tremor is associated with visually guided 
movements toward a target, for example, when performing the finger to nose test. 
Isometric tremor occurs while holding up heavy weights. Task-specific tremor is 
associated with specific task or movement, such as writing or speaking. (Zesiewicz 
and Hauser, 2001).
1.3.2. Classification of tremor by Aetiology
Physiological tremor is a small amplitude, rapid and irregular oscillation at 8-12 Hz 
of the hand (Velickovic and Gracies, 2002). It may occur at rest. It is unlikely to be 
caused by activity in the central nervous system since, by definition at rest there is no 
neuromuscular activity. It has been attributed to the ballistocardiogram (Yap and 
Boshes 1967; Marsden, Meadows, Lange and Watson 1969). There are small 
mechanical perturbations originating in the arterial pulse, which produce oscillations 
at about 10 Hz by peripheral passive mechanical resonance.
Enhanced physiological tremor is another type of tremor that is seen in both healthy 
people and patients. It is a postural tremor of the hands with a frequency range of 8- 
12 Hz when the limbs are outstretched. It has been described as a mechanical 
resonance because the tremor frequency changes with loading (Lakie, Walsh and 
Wright, 1986). It has been proposed that it originates in resonance in the peripheral 
stretch reflex loop. (Halliday and Redfearn, 1956; Hagbarth and Young, 1979; 
Sakamoto and Nishida, 1992).
Conditions known to cause enhanced physiological tremor include the following: 
thyrotoxicology, hypoglycemia, p-adrenergic drugs, dopaminergic drugs and 
adrenaline. Adrenaline increases the sensitivity of the muscle spindles and thus 
enhances rhythmic afferent activity. This leads to greater synchronisation of the 
afferent volley and enhanced reflex activity, an ultimately synchronised motor unit 
firing (Deuschl, Raethjen, Lindemann and Kiack, 2001).
Essential tremor is the most common movement disorder in familial cases. It usually 
occurs before a person reaches 30 years (Smaga, 2003). It may be inherited, but the 
exact genetic defect has not been identified (Hallett, 1991). The tremor amplitude 
increases as the hand approaches a target. The frequency of essential tremor lies in 
the range 4-12 Hz. The aetiology, pathology, pathophysiology and neuro­
pharmacology of essential tremor are generally poorly understood.
Essential tremor is an action tremor, either postural or kinetic in character. It mainly 
affects the hands. It is usually bilateral with a frequency of 4 Hz to 12 Hz and largely 
symmetrical. (Louis, 2001) The upper limbs are affected in about 95% of patients. 
The head is affected in about 34% of patients. Essential tremor is less common in the 
lower limbs, with 20% of patients affected. It can also affect the voice in about 12% 
of patients, as well as the face and trunk (5% of patients) (Elbie, 2000a). In a 10- 
year follow up study (Elble,2000b) the frequency of the essential tremor was seen to 
decrease and the amplitude increased.
The prevalence of essential tremor ranges from 0.4% to 6.7% in persons over 40 
years old so it is the most common type of tremor (Brin and Roller, 1998; Bharucha, 
Bharucha and Bharucha, 1988; Haerer, Anderson and Schoenberg, 1982). Many
studies have shown that essential tremor is up to 20 times more common than 
Parkinsonian tremor (Louis, Ford and Frucht, 2001; Bain, Findley and Thompson 
1994). However, some experts suspect that the essential tremor might be over­
diagnosed by clinicians (Schrag, Munchau and Bhatia, 2000).
Parkinson’s disease is associated with a slow degeneration of a small area in the 
midbrain called the substantia nigra. The age of onset is typically 60-70 years, but 
not uncommonly before 60 years, and both sexes are equally affected. The tremor 
commonly involves the head, jaw, neck, facial muscles, tongue and upper extremities 
but not the lip, which suggests the tremor of Parkinson disease in those cases. 
Parkinson’s disease is associated with a slow degeneration of a small area in the 
midbrain called the substantia nigra. Specifically, excitatory and inhibitory 
dopaminergic neurones are affected. (Lenz, Normand, Kwan, Andrews, Rowland and 
Jones, 1995). The frequency lies in the range 4-6 Hz for the hand. It can also affect 
the head, trunk, jaw and lips. (Anouti and Roller, 1995; Sandroni and Young, 1994).
Parkinsonian tremor typically occurs at rest and becomes less prominent during 
voluntary movement. It usually occurs first in the distal part of one upper limb and 
over time, moves proximally. Ultimately, the tremor spreads to affect the other upper 
extremity, again in a distal to proximal pattern. Seventy per cent of patients with 
Parkinson’s disease have tremor. Other Parkinsonian patients have early postural 
instability and akinesia. (Bhidayasiri, 2005).
Action and postural tremors occur in patients with Parkinson’s disease. They can 
occur alone or in combination. Parkinsonian tremor is most commonly a 
combination of postural and kinetic tremors. Pure resting tremors or pure postural
/kinetic tremors are rare. The variability of the clinical expression of tremors in 
Parkinson’s disease makes diagnosis difficult. It is based on a general diagnosis of 
Parkinson’s disease rather than on specific features of tremors. Only the rest tremor 
component is by itself, a positive diagnostic criterion for Parkinson’s disease 
(Bhidayasiri, 2005).
Kinetic tremor is the most common type of cerebellar tremor. It presents as a 
unilateral or bilateral tremor with a peak frequency below 5 Hz. The tremor 
amplitude increases during goal-directed movements. Cerebellar tremor is due to 
diseases or lesions of the cerebellum and cerebellar outflow tracts. Classically, the 
lesion lies within one cerebellar hemisphere or is caused by a stroke, tumour or 
neural degeneration of the cerebellum nuclei. These lead to an action tremor on the 
same side of the body as the lesion. Midline cerebellar diseases may cause tremor of 
the arms, the head or the trunk (Anouti and Koller, 1995).
Cerebellar postural tremor can also follow cerebellar damage. It has a frequency 
range of 2.5 to 4 Hz. The milder form of tremor has a more rapid frequency at 10 Hz 
and it appears in more distal limb segments (Hallett, 1991).
Other tremors
Orthostatic tremor is defined as postural tremor of the legs associated with the 
initiation of standing, walking or sitting. The frequencies range from 13 to 18 Hz. 
(McManis and Sharbrough, 1993; Gates, 1993).
Multiple sclerosis is the most common cause of the cerebellar postural tremor 
(Zesiewicz and Hauser, 2001). Tremor can also be associated with peripheral 
neuropathies where it is clinically similar to essential tremor but the aetiology is 
different. It can be caused by demyelination or by diabetic peripheral neuropathies 
(Anouti and Koller, 1995).
1.3.3. Classification of tremor by physiological factors
Physiological tremor is probably the best-known form of tremor. It consists of three 
main components: a mechanical component, a reflex component and a central 
component.
Mechanical component
This is responsible for the main frequency components of tremor in most normal 
subjects (Deuschl et al, 2001). The mechanical component consists of a damped 
oscillation which is driven by several factors: a resonance at 8 Hz (Timmer, Lauk, 
Pfleger and Deuschl 1998), a cardioballistic effect which is a small impulse due to 
the arrival of the pulse wave followed by a damped oscillation (Marsden, 1984). The 
resonance frequency can be identified by spectral analysis of position or 
accelerometer signals or from EMG signals. The mechanical tremor components can 
be characterised by loading the extremities with weights to change the resonance 
frequency (Deuschl et al, 2001).
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Reflex component
Muscle spindles are very sensitive to small oscillations in muscle length (Matthews, 
1981). The mechanical oscillations of physiological tremor are associated with 
rhythmic modulation of spindle activity, but reflex-induced modulation of the 
electromyogram occurs only when tremor is enhanced by fatigue or by drugs 
(Lakieet af, 1986; Stiles, 1976, 1980; Young and Hagbarth, 1980). The principal 
rhythmic component of physiological tremor is referred to as mechanical reflex 
tremor, not mechanical tremor (Stiles, 1983). Marsden and Meadows (1968) studied 
adrenaline-induced tremors. They reported that adrenaline increases the sensitivity of 
the muscle spindles and thus enhances rhythmic afferent activity. This leads to 
greater synchronisation of the afferent volley and enhances reflex activity.
Any movement in one direction e.g. a flexion will stretch the extensor muscles and 
cause an afferent volley eliciting reflexes in the extensors. While the extensor is 
activated, the flexor will be stretched causing an afferent volley from the flexors. 
When the reflex gains and the conduction time for the afferent and efferent 
conduction are appropriate, an oscillation will result (Stein, Lee and Nichols, 1978; 
Stein and Lee 1981).
Reflex and mechanical contributions to tremor can be identified during loading and 
unloading of the limb (Deuschlet al. 2001). In the unloaded condition significant 
peaks are found in the frequency spectrum of the EMG and accelerometer signals. In 
the loaded condition the peaks that are shifted to the lower frequencies are due to 
mechanical factors whilst those mediated by reflexes are unaltered.
1 1
Central component
This component has been attributed to different mechanisms (Elble and Koller,
1990). Neither somatosensory nor visual feedback seems to play a significant role 
(Stephens and Taylor, 1974). The central component may be caused by motor 
neurones firing at 8-12 Hz. This does not produce a fused contraction (Allum, Dietz, 
and Freund, 1978; Freund, 1983). The unfused contractions are subsequently 
synchronised by reflex mechanisms. However, Elble and Randall (1976) 
demonstrated that single motor units fire at much higher frequencies, up to 22 Hz. 
Spectral analyses of both EMG and tremor showed coherence at the 8 to 12 Hz in 
both signals. This was explained by either Renshaw cell inhibition in the spinal cord 
or central oscillators located in the inferior olive or thalamus (Elble and Koller,
1990). This idea has been expanded in several studies that investigate subjects with 
congenital mirror movements. Here the 8-12 Hz components are coherent in both 
arms (Koster, Lauk, Timmer, Wenter, Guschlbauer, Glocker, Danek, Deuschl and 
Lucking, 1998). In normal subjects these components do not cohere (Lauk, Koster, 
Timmer, Guschlbauer, Deuschl and Lucking, 1999; Raethjen,Pawlas, 
Lindemann,Wenzelburger and Deuschl, 2000). Patients with mirror movements have 
bilateral projections of the cortico-spinal tract, making it likely that this tremor 
component is transmitted through the tract. This implies that the oscillator is located 
either within or central to the motor cortex.
It has been reported that movements of the digits and forearm are regulated through 
an 8-12 Hz pattern of bursts in motor neurones (Vallbo and Wessberg, 1993) which 
is independent of the stretch reflex (Wessberg and Vallbo, 1996). This rhythm is 
transmitted to both agonists and antagonists (Wessberg and Kakuda, 1999). This 
reflects a common central input.
1 2
Rajethjen, Pawlas, Lindemann, Wenzelbiirger and Deuschl (2000) reported that 8-12 
Hz central components contributed to the clinical expression of physiological tremor. 
They estimated that central components made a significant contribution to tremor 
amplitude in only 30% of normal subjects. They believe this contribution to be much 
higher in persons with enhanced physiological tremor. They found reflex-driven 
tremor was found in only 2% of normal subjects.
All these studies suggest that the central component of physiological tremor is due to 
synchronisation at the cortical level by mechanisms inherent in the organisation of 
the motor system.
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Figure L I A diagram showing motor pathways where 10 Hz physiological tremor 
may arise.
From M cA uley and Marsden, (2000).
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Tremor
;
Rest
Others Parkinson’s 
Disease
:
Action
Postural
1
i
Kinetic
1
Physiological
t
Cerebellar
Enhanced Disease,
Physiological Multiple
Essential, Sclerosis,
Holmes,
Rubral
Tremor Type Site Amplitude Frequency Range
Parkinson disease Hand, Head, Trunk Medium 3-6 Hz
Postural Hand, Head, Voice Low-Medium 4 -  12 Hz
Kinetic Arm, Hand High Variable
Task Specific Distal muscles of arm Variable 4 -  10 Hz
Figure 1.2. The diagram shows the classification of tremor. The table shows the 
characteristics of tremor.
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1.4. Clinical Management of Tremor
There are three main ways in which tremor is managed clinically. Most commonly, 
they are left untreated because they do not interfere too significantly with the 
patient’s daily living activities. In addition, there are drugs which can be used to 
manage the tremor. In a small number of severe cases, a neuro-surgical solution will 
be sought. Each of these will be described in turn. The next section (1.4.1) will 
describe aspects of the treatments of essential tremor. Section 1.3.2 described how 
this is the largest patient group i.e. there may be 20 times more cases of essential 
tremor than Parkinsonian tremor. There are alternative treatments for the smaller 
patient groups but they are not reviewed here.
1.4.1. Non-pharmaceutical and non-surgical treatments
The risks and cost of neurosurgery and the difficulties of unwanted side effects in 
drug therapy have lead many people to try more natural treatments. Essential tremor 
is one of the most common movement disorders. The report prevalence of essential 
tremor varies greatly with estimates from 0.8 to 2200 per 10000 populations. The 
majority of studies estimate the prevalence between 40 and 400 per 10000 of 
populations (Louis, Ottman, Ford and Hauser, 1998). Tremor can develop at any age, 
but typically it begins in middle age. Essential tremor increases in prevalence with 
increasing age. It is estimated that between 1 and 5 of every 100 persons aged over 
60 years is affected. (Louis et al. 1998).
It is well known that adding weights to a tremulous limb can reduce the amplitude of 
the tremor thought it does not eliminate the tremor as originally thought (Lynos,
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Pahwa, Cornelia, Eisa, Elble, Fahn, Jankovic, Jimcos, Koller, Ondo, Sethi, Stern, 
Tanner, Tintner and Watts, 2003). Such loading may be helpful while performing 
directed tasks such as eating or drinking. This technique is helpful in identifying 
psychogenic tremor, as weight tends to decrease organic tremor but increase 
psychogenic tremor (Lyons et al, 2003). The use of relaxation techniques such as 
meditation, yoga, hypnosis and biofeedback approaches can reduce tremor in some 
patients for short periods (Lyons et al, 2003). These techniques are particularly 
useful during time of increased stress.
1.4.2. Pharmacological management
Drug treatment for some types of tremor is well established. A range of drugs used is 
given in Table 1.1. It is clear from the length of this drug list that there is no single 
popular drug treatment, which is more effective than another. The difficulties with 
effective drug treatment may reflect problems of drug entry to the brain through 
blood brain barrier. In addition, since the origins of tremor are complex, many sites 
in the brain will be involved.
Some drug therapies may be satisfactory in some patients and ineffective in others.
In addition, the mode of action of each drug is unclear. The drugs may also have side 
effects either centrally, i.e. somnolence is associated with Gabapentin or peripherally
i.e. the |3-blocker actions of propranolol.
However, at present there are no easy cures or treatments of tremor. Neither are there 
any drugs that can slow the progression of tremor (Lyons et al, 2003).
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A variety of drugs have been used to treat tremor in Parkinson’s disease. The 
principle drugs used include: levodopa, dopamine agonists, anticholinergics and 
budipine. Clozapine, propranolol and clonazepam have also been used as second line 
treatments (Wasielewski, Burns and Koller, 1998).
Anticholinergics, such as trihexylphenidyl, are effective in tremor management but 
rarely used now because of their side effects like drowsiness. Anticholinergics are 
not generally recommended for use in patients with cognitive problems or in elderly 
patients (Katzenschlager, Sampaio and Costa, 2003).
Levodopa can produce remarkable reductions in tremor in patients with Parkinson’s 
disease. In contrast, dopaminergic treatment is less successful in improving akinesia 
and rigidity in Parkinsonian patients (Koller and Hubble, 1990). However, there are 
few double blind, randomised trials specifically designed to assess the efficacy of 
drug treatment in the management of tremor in early Parkinson’s disease (Koller, 
1986; Wasielewski, Burns and Koller, 1998; Hughes, Lees, and Stern, 1990).
The dopamine agonists pramipexole and ropinirole are probably the most effective 
anti-tremor drugs (Navan, Findley and Jeffs, 2003; Pogarell, Gasser and van Hilten, 
2002; Schrag, Keens and Warner, 2002). Two other dopamine agonists, pergolide 
and bromocriptine also produce good results (Korczyn, Brunt and Larsen, 1999; van 
Laar, Lledo and Quail, 1999). Dopamine agonists are also useful in patients with 
advanced Parkinson’s disease even when treatment with levodopa and 
anticholinergics has failed (Pogarell, Gasser and van Hilten, 2002).
Clinical trials in which there has been transplantation of embryonic dopamine 
neurones into the brains of patients with Parkinson’s disease have taken place over
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the last 15 years (Freed, Breeze and Rosenberg, 1990; Lind vail, Brundin and Widner 
1990; Freed, Breeze, Rosenberg, Schneck, Kiiek, Qi, Lone, Zhang, Snyder,Wells, 
Ramig, Thompson, Mazziotta, Huang, Grafton, Brooks, Sawle, Schroter and Ansari 
1992).Since that time, a number of open clinical trials have described clinical 
improvements after transplantation. The validity of these observations is uncertain 
because of the small numbers of subjects, variable inclusion criteria and a lack of 
controls.
The strongest clinical conclusions come from double blind trials with a large group 
of patient volunteers. One such study followed patient progress for five years after 
transplantation (Freed, Bjugstad, Breeze,Greene, Eidelberg and Fahn 2002). They 
found no improvement of tremor in the transplantation group.
A second double-blind trial was published by Olanow, Goetz, Kordower, Stoessl, 
Sossi, Brin, Shannon, Nauert, Perl, Godbold and Freeman in 2003. This study was 
designed to test the effect of tissue dose. The result of sham operations were 
compared to transplants of tissue from two embryos or six to eight embryos per 
patient. The results were followed over a period of 2 years. PET scanning showed 
greater outgrowth of neurites from the larger dose transplants at 12 months. The 
growth from the smaller grafts caught up with the larger dose grafts after 24 months. 
There was no change in patients who received sham operations. However, this study 
failed to see any improvement in unified Parkinson’s disease rating scale (UPDRS) 
motor “o f f ’ scores in the transplanted group compared to controls.
There limitations to wide scale testing and application of neuro-transplantation. One 
is the limited availability of human embryonic neurons. Laboratory production of
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large quantities of neurons from stem cells could solve this problem. However, there 
are still major ethics issues to be resolved.
2 0
Tremor type Medication Possible side effects
Essential Tremor Alcohol Abuse, adverse general health 
Effects
Propranolol (Inderal) Congestive heart failure, 
bronchospasm, sympathetic 
response to hypoglycaemia 
blocked, bradycardia, nausea, 
vomiting, depression, 
impotence, fatigue, insomnia
Clorazepate (Tranxene) Sedation, addiction, increase 
limited by fatigue, paradoxical 
agitation
Clonazepam (Klonopin) As for Clorazepate
Botulinum toxin Severe muscle weakness
Gabapentin (Neurontin) Somnolence, fatigue
Primidone (Mysoline) High incidence of initial side 
effects; flu-like symptoms with 
ataxia (25%); rare bone- 
marrow suppression
Rest tremor 
Parkinson disease
Trihexyphenidyl
(Artane)
Dry mouth, blurred vision, 
dizziness, nausea/vomiting
Cai'bidopa levodopa 
(Sinemet)
Involuntary dyskinetic 
movements, rare CNS effects
Amantadine
(Symmetrel)
Multiple CNS effects
Cerebellar tremor Buspirone (Buspar) Poor response.
Orthostatic tremor Clonazepam (Klonopin) CNS depression, drowsiness, 
ataxia
Table 1.1. Drugs used in the treatment of tremor.
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1.4.3. Surgical treatment of tremor.
Surgical therapy for tremor is only considered if drug therapy fails to produce 
adequate relief. There ai’e multiple reports regarding the efficacy of thalamotomy for 
essential tremor. (Lynos, Pahwa, Cornelia, Eisa, Elble, Fahn, Jankovic, Juncos, 
Koller, Ondo, Sethi, Stern, Tanner, Tintner and Watts, 2003). These reports have 
consistently shown that over 90% of patients have experienced improvements in 
tremor contralateral to the side of the thalamotomy. Long-term follow-up studies 
have indicated that the benefits of thalamotomy can continue for up to 20 years 
(Lyons et al, 2003). One study of the use of stereotactic thalamotomy in the 
treatment of tremor (Goldman, Ahlskog and Kelly, 1992) evaluated eight patients 
with essential tremor following ventral intermediate thalamotomy (seven unilateral, 
one bilateral). It reported that contralateral tremor resolved or was markedly 
improved in all patients at a mean follow-up date of 17.3 months after surgery. Two 
patients reported mild dysarthria, and one patient suffered mild cognitive 
impairment. Janckovic, Cardoso, Grossman and Hamilton, (1995) evaluated six 
essential tremor patients at a mean interval of 53.4 months after VIM thalamotomy. 
They found that five of the patients had total resolution or moderate to marked 
improvement in contralateral tremors.
An earlier study by Mohadjer, Goerke and Milios (1990) reported that at a mean 
follow up of 8.6 years after thalamotomy, 89% of the 65 patients with essential 
tremor showed improvement. 86% percent of the 42 patients with Parkinsonian 
tremor improved. Postoperative complications included weakness, dysarthria and 
confusion. In addition, bleeding in the thalamus or in the subdural or epidural area
2 2
was recorded during surgery. This is very serious and can lead to death, paralysis, 
aphasia or cognitive deficits.
Variation in morbidity and mortality statistics can be related to different techniques 
of the procedure. Bilateral thalamotomy is not recommended due to increased 
morbidity and mortality rates. One of the main concerns is the risk of speech 
difficulty associated with bilateral thalamotomy. Tasker (1993) reported a life time 
mortality experience with thalamotomy of <0.5%.
Stereotactic surgery can alleviate contralateral limb tremor in patients with 
Parkinson's disease, essential tremor, dystonie tremor syndromes, writing tremor, 
Holmes' tremor, post-traumatic tremor and tremulous multiple sclerosis (Goldman 
and Kelly, 1995). The preferred intra-cerebral target in the surgical treatment of 
Parkinsonian tremor is the sub-thalamic nucleus rather than the nucleus ventralis 
intermedins of the thalamus (Obeso, Olanow, Rodriguez-Oroz, Kiack, Kumar and 
Lang, 2001). The thalamus has been the target of choice for stereotactic surgery for 
relief of essential, dystonie and Holmes' tremor. Lesions placed in the nucleus 
ventralis oralis posterior or zona incerta may be as effective as those in the nucleus 
ventralis intermedins. In cases of multiple sclerosis, the zona incerta may be the 
preferred target (Alusi, Worthington, Glickman and Bain, 2001). Presently deep brain 
stimulation is considered to be safer than stereotactic surgery (Schuurman et al., 
2000).
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Deep Brain Stimulation
Deep-brain stimulation through an electrode implanted in the thalamus can be used as 
an alternative to thalamotomy for the treatment of drug-resistant tremor. In 1987, 
Benabid and his colleagues successfully treated a number of Parkinsonian patients, 
whose tremor was not improved by drug treatment, with chronic stimulation of the 
ventro-intermediate nucleus of thalamus (Benabid, Poliak and Lou veau, 1987). This 
followed the pioneering work of several neurosurgeons who had applied electrical 
stimulation to different thalamic nuclei to treat tremor or other dyskinesias 
(Bechtereva, Kambarova and Smirnov, 1975; Brice and McLeilan, 1980; Mazars, 
Merienne and Cioloca,1980; Andy, 1983; Siegfried, 1986).
Subsequently, Benabid and his colleagues reported on a larger group of patients who 
had received thalamic stimulation. This included 26 patients with Parkinson’s disease 
and 6 patients with essential tremor. They found tremor suppression in 88% of these 
patients (Benabid, Poliak, and Gervason, 1991).
In 1992 a European multi-centre study started. Its aim was to evaluate the efficacy of 
chronic unilateral or bilateral thalamic stimulation in the treatment tremor. The study 
followed 110 patients attending 13 centres over 12 months. It found improvement in 
the tremor in 85% of Parkinsonian patients and in 89% of the patients with essential 
tremor. The effects of stimulation on other Parkinson symptoms such as rigidity and 
its effect on the activities of daily living were also evaluated. It was found that the 
drug treatments were unchanged over the period, probably because some Parkinson 
symptoms were not controlled by thalamic stimulation (Limousine, Speelman,
Gielen and Janssens, 1999). Earlier studies also found that only one third of
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Parkinsonian patients have their drug dosage decreased whilst being treated with 
thalamic stimulation. The drug dosages in patients with essential tremor show similar 
trends (Benabid, Poliak and Gervason, 1991; Benabid, Poliak and Seigneuret, 1993).
The effects of stimulation and thalamotomy in improving the functional abilities of 
patients with drug-resistant tremor due have been compared (Schuurman, Bosch, 
Bossuyt, Bonset, van Someren, Merkus and Speelman, 2000). In this study, 68 
patients were randomly assigned to undergo thalamotomy or thalamic stimulation. 
The patient group included: 45 with Parkinson's disease, 13 with essential tremor and 
10 with multiple sclerosis. Thalamic stimulation and thalamotomy were found to be 
equally effective for the suppression of drug-resistant tremor, but thalamic 
stimulation had fewer adverse effects and results in a greater improvement in 
function.
However, Ondo, Jankovic and Schwartz (1998) stated that the surgical approach to 
the target in the brain is dangerous and this form of surgery is limited to a small 
number of very serious cases.
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Topical anaesthetic actions and penetration into skin.
Previous studies have been made into the action of topical anaesthetics on tremor. 
(Pozos and lazos, 1992; Pozos, Mills and lazos 1994; Mills and Pozos, 1995). This 
section will cover the literature on the actions of topical anaesthetics on sensory 
nerves in human skin.
In the resting state, the neurone has a membrane potential of about -70 mV. The 
resting potential is largely determined by the concentration gradients of 2 major ions, 
and Na"^  and their relative membrane permeabilities. Local anaesthetics inhibit 
depolarisation of the nerve membrane by interfering with both Na'^ and currents 
(Gmyrek and Dahdah, 2006). Two theories have been proposed to explain this. The 
membrane expansion theory postulates that the local anaesthetic is absorbed into the 
axon membrane where it causes expansion of the membrane leading to narrowing of 
the sodium channels. This hypothesis has largely given way to the specific receptor 
theory. This theory proposes that the local anaesthetic diffuses across the cell 
membrane and binds to a specific receptor site at the opening of the voltage-gated 
sodium channel. This leads to alterations in the structure or function of the channel 
and inhibits sodium ion movement. This blocks depolarisation and action potential 
transmission. Blockade of leak currents by local anaesthetics may also contribute 
to conduction block by reducing the ability of the channels to set the membrane 
potential (Gmyrek and Dahdah, 2006).
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Nerve fibres are categorized into three groups A, B and C on the basis of their axon 
diameter (Erlanger and Gasser, 1937). The A fibres are the largest diameter and 
myelinated. B fibres are of moderate diameter and myelinated. Type C fibres are the 
smallest and unmyelinated. Local anaesthetics affect each group differently 
(McKenzie, Burke, Skuse and Lethlean, 1975). The smaller diameter fibres are more 
sensitive and as result C fibres are blocked more easily than A fibres. The anaesthetic 
must act on several millimetres of the axon to block the transmission of the nerve.
This gross classification of afferent axons by fibre size can be extended to 
incorporate information on types of sensory endings and adaptation characteristics. 
Details of this are given in table 1.2. In brief, the A(3 axons in cutaneous nerves 
include those from Meissner's corpuscles and hair follicles (classified as FA I), 
Pacinian corpuscles (classified as FA II), Merkel's disks (classified as SA I) and 
Ruffini endings (classified as SA II). The pain sense is associated with A5 and C 
axons arising from free nerve endings.
The stratum corneum, the outermost layer of skin, is the principle barrier to 
penetration of any drug through the skin (Koh, Harrison, Flock, Marchitto and 
Martin, 2003). Topical anaesthesia is effective in the most superficial 2-3 mm of skin 
(Koh et al., 2003). Removal of the stratum corneum by tape stripping increases the 
penetration of topical anaesthetics about eightfold (Kao, Patterson and Hall, 1985). 
Another method of increasing the penetration across the stratum corneum of topically 
applied local anaesthetics is by iontophoresis. (Sarpotdar and Zatz, 1986; Greenbaum 
and Bernstein, 1994; Monteirro-Riviere, 1990).
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The main reason for the application of topical anaesthetics is to reduce cutaneous 
pain sensation in a clinical setting. Most studies test pain sensation after application. 
Jeffrey, Dale, Stephen, Kevin and Timothy (2003) investigated pain after topical 
anaesthesia produced by 4 and 10% lidocaine in 50 adult volunteers. The sensation 
was tested by application of laser light five and ten minutes after application of 
topical anaesthetic. The pain felt after each pinprick using the 0 - 10 scale were 
tested. 86% of the participants described the sensation of the laser ablation as non 
painful i.e., “puff of air”, “no sensation”. The others described the sensation as a 
“pinch”, “poke” or “sting”. No difference in pain scores after application of 4% and 
10% lidocaine or after 5 minutes or 10 minutes of application.
1.5, Local anaesthesia of skin as a treatment for tremor
It is clear that whilst tremor is a major clinical problem, there is no satisfactory 
treatment available. One novel approach has been to try to change the reflex 
components of tremor by reducing the cutaneous sensory inputs with topical 
anaesthesia.
Techniques based upon the modification of information transmission in the brain 
have been used successfully for the rehabilitation of movement disorders and 
spasticity (Kelly, Baker and Wolf, 1979). Topical anaesthesia has been used to 
reduce cutaneous inputs (Sabbahi, De Luca and Power, 1981; Sabbahi and De Luca, 
1982; W olf and Minkwitz, 1989; Agostinucci and Power, 1992; Arsenault, Belanger, 
Durand, De Serres, Fortin and Kemp, 1993; Agostinucci, 1994). These studies have 
reported varying results, ranging from no effect on motor neurone excitability in
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normal subjects (Arsenault et a l ,  1993) to increased range of joint movement during 
gait in patients recovering from stroke (Sabbahi et a l ,  1981). Pozos and laizzo 
(1992) investigated the use of topical anaesthesia of the forearm in the treatment of 
patients with essential tremor. The patients were concurrently treated with 
propranolol. They reported a significant reduction in the amplitude of tremor, 20-30 
minutes following application. They found no change in the frequency of the tremor. 
This probably indicates that the tremor frequency is mostly determined by 
mechanical characteristics and that the amplitude is mostly determined by reflex 
characteristics.
Topical anaesthesia of skin decreases the excitability of motor neurones supplying 
muscles in the lower limb (Sabbahi and De Luca, 1981). These experiments use an H 
reflex testing method. The authors had no information about the mechanism which 
reduced the H reflex excitability. They speculated that the change was brought about 
by modulation of gamma motor neurone activity.
Many factors ai'e known to affect the H-reflex recovery. These include; inhibition of 
the motor neurone pool by group II afferents (Magladery and Porter, 1951), recurrent 
inhibition by Renshaw cells (Haase, 1975), Ib afferent inhibition (Hufschmidt, 1966), 
feedback from the muscle spindles and joint receptors leading to inhibition 
(Taborikova and Sax, 1969), supraspinal inhibition (Taborkova, 1973) and depletion 
of the transmitter substances (Taborihova and Sax, 1969).
Sabbahi and Deluca (1981) added modulation of cutaneous afferent nerves to this 
list. They tested the amplitude of soleus H reflexes before and after application of 
20% benzocaine to produce topical anaesthesia of various areas of skin on the leg.
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The skin covering gastrocnemiiis-soleus, quadriceps, anterior tibial muscles and 
hamstring were investigated. In other experiments, areas of skin corresponding to the 
L2, L3, L4, L5, S 1 and S2 dermatomes of the lower limb were anaesthetised. They 
found similar results in both experiments. The amplitude of H-reflexes increased 
following application of the anaesthetic whilst the amplitude of the Achilles tendon 
reflex remained unchanged. The authors reported that input from cutaneous afferents 
might have an important inhibitory effect on the gamma motor neurones supplying 
soleus. Earlier, Sabbahi and Sedgwick (1976) tested monosynaptic reflexes during 
natural mechanical and thermal stimulation to the skin. Cutaneous stimulation 
produced inhibition of the H reflexes.
The effect of topical anaesthesia on motor performance has been investigated in 
patients with a range of clinical problems such as stroke, head injury and familial 
spino-cerebellar degeneration (Sabbahi, 1987). Clinical studies report an increase in 
the active and passive range of movement of joints, improved speed of movement as 
well as reductions of muscle stiffness (Sabbahi, Roy, De Luca and Van Volkinburg; 
1983; Sabbahi and De Luca, 1981). The authors reported that the degree of 
improvement varied between head-injured and stroke patients. The improvement 
occurred within 15-30 minutes after xylocaine application. Mills and Pozos (1985) 
reported a significant reduction in the amplitude of the physiological clonus, 
physiological action tremor at the ankle in normal volunteers after application of 
topical anaesthesia to the skin of the leg, ankle and proximal half of the foot. In 
addition, pathological clonus in spinal cord injured volunteers was also reduced. 
Furthermore, W olf and Minkwitz (1989) studied the Achilles tendon reflex, H- 
reflexes and the range of motion of the ankle in stroke patients before and after 
application of a benzocaine anaesthetic spray to the skin of the lower limb. They
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reported no significant difference between the application of a placebo spray and 
benzoeaine spray. In both cases the excitability level of motor neurones increased 
and there was improvement in the subject’s ability to perform a motor task. The 
authors attributed these effects of skin stimulation to the topical application of the 
spray rather than to any drug action.
Similar studies have been performed in the upper limb. Sabbahi, Mason and Gleeson 
(1985) studied the H-reflex of the flexor carpi radialis muscle in normal volunteers. 
The reflexes were elicited by electrical stimulation of the median nerve. They applied 
topical anaesthetics to the skin of the anterior forearm, anterior arm, posterior 
forearm and posterior arm and this resulted in increased amplitude of H-reflexes. The 
authors reported that all skin areas of the upper limb, except for the posterior 
forearm, provided inhibitory inputs to the flexor gamma motor neurone pool of the 
flexor carpi radialis. It appears that posterior forearm skin provided a strong 
excitatory input to the flexor gamma motor neurone pool of the flexor caipi radialis.
Several experiments demonstrate the existence of ongoing inhibitory and excitatory 
effects from skin afferents on the alpha and gamma motor neurone pools via 
segmental and supra-segmental pathways. The reduction in the activity or discharge 
from cutaneous afferents, caused by topical anaesthesia, changes the excitability of 
the motor neurone pools (Sabbahi and De Luca 1981, 1982).
1.6. Innervation of forearm hairy skin
Each peripheral cutaneous nerve contains afferent and efferent nerve fibres 
innervating a particular skin area. The skin region supplied by afferent fibres in one
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dorsal root is called a dermatome. The dermatomes of adjacent dorsal roots overlap 
extensively. The extent of overlap varies with modality of sensation. For instance, it 
is less for pinprick pain than for light touch (Greger and Windhorst, 1996).
At least six different kinds of endings occur in the skin as shown in Fig. 1.3. (Moffat 
and Mottram, 1987). There are two major types of receptor response to sustained 
stimulation: slow adapting (SA) and fast adapting (FA) see table 1.2. Each of these 
types subdivides into two subgroups: SA I, SA II and FA I, FA II. These four 
cutaneous afferent types innervate the human hand.
The properties of mechanoreceptors in human hairy skin of the back of hand were 
studied by Jarvilehto, Hamalainen and Soininen (1981). They identified a total of 
264 mechano-receptive units. 66% were classified as slowly adapting (SA) and 34% 
as fast adapting (FA) units. Most SA I and FA units were able to signal the stimulus 
amplitude on the basis the of number of impulses. Only FA units could signal the 
stimulus velocity.
There are some differences between the characteristics of receptors in hairy and 
glabrous skin. Receptors in human hairy skin do not seem to differ from the 
corresponding receptors in other animals (Jarvilehto et al., 1981).
The first account of hairy skin receptor responses to joint movements was published 
by Edin and Abbs, 1991. They found that more than 90% of the 121 receptors 
located on the back of the hand responded to finger movements. The receptors in the 
human hairy skin provide information on nearby joint positions and therefore may 
play a specific role in proprioception, kinaesthesia and motor control, (Benoni and 
Edin, 1992). However, the receptors in hairy skin play a more important role than
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those in glabrous skin in providing information on joint position and movements. 
Hairy skin lacks the tight connections to subcutaneous tissues that are present in 
glabrous skin and can therefore be both moved and stretched with little resistance by 
movements at nearby joints. Every joint of the human body is covered by hairy skin 
and thus skin may be able to signal information on movements (Hulliger, Nordh, 
Thelin and Vallbo, 1979).
1.7. Skin receptors
There have been several investigations of the sensations or perceptions associated 
with activation of each type of afferent. (Johnson, 2001). The SA I afferent system 
provides a high quality neural image of the spatial structure of objects and surfaces.
It is the basis of form and texture perception. The FA system provides a neural image 
of motion signals from the whole hand. The Pacinian corpuscle system provides a 
neural image of vibrations transmitted to the hand from objects contacting the hand. 
Lastly, the SA II system provides a neural image of the skin stretched over the whole 
hand (Johnson, 2001). Some slowly adapting SA receptors show graded responses to 
finger movements even when they were located 6 to 7 cm from the joint (Edin and 
Abbs, 1991).
The receptors in human hairy skin do not differ in their characteristics from the 
receptors in human glabrous skin or from receptors in the hairy skin of animals 
(Jarvilehto, Hamalainen and Laurinen, 1976). Both glabrous and hairy skin contains 
receptors that respond to maintained indentation. These are the Merkel and Pimkus- 
Iggo corpuscles, which lie immediately below the epidermis, and the Ruffini 
corpuscles, which lie deeper (Greger and Windhorst, 1996).
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Rate of adaptation
Fast Slow
FA I-Meissner or Hair Follicle 
Surface receptors 
Small field 
Localised epidermis 
Edge sensitive- feels like 
localised flutter- used for 
recognising texture
SA I Merkel
Surface receptors
Small field
Localised epidermis
Edge sensitive-used for noting
fine surface edges
FA II—Pacinian
Deep receptors
Largest field
Localised dermis
Activated by diffuse vibration
e.g. tapping with a pencil
SA II Ruffini
Deep receptors
Large field
Localised dermis
Sensitive to lateral skin stretch
used for joint position in finger
Table 1.2 Summary of the types of cutaneous mechanoreceptor and some of their 
distinguishing properties.
The left panel show s the characteristics o f  fast adapting receptor types (FA I, II). The right panel 
show s the characteristics o f  slow  adapting receptor types (SA  I, II).
1.8. Skin structure:
The skin is the largest organ in the body accounting for 16% of body weight.
(Greger and Windhorst, 1996). It has several important functions including sensation. 
The skin structure consists of three layers; epidermis, dermis and subcutaneous fat.
1.8.1. Epidermis
The epidermis layer contains no blood vessels and depends on the underlying dermis 
for nutrient delivery via diffusion through the dermo-epidermal junction. Most layers
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of epidermis are only 0.1 to 1.5 millimetres thick. The epidermis is made up of five 
layers: the basal cell layer, the squamous cell layer, the stratum granulosum, the 
stratum lucidum and the stratum corneum.
1.8.2. Dermis
The dermis lies under the epidermis and supports it. The dermis is 1.5 to 4 
millimetres thick. The main components of the dermis are collagen and elastin. It 
contains most of the skin structure including sweat and oil glands, hair follicles, 
nerve endings, blood and lymph vessels.
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Epidermis
Dermis <
Subcutaneous
layer
B asal cell m em brane
B asal cell 
S quam ous cell 
Horny layer 
Hair follicle 
Dendritic cells 
M elanocytes
M eissn e r's  co rpuscu les 
S eb ac eo u s  g lands 
A rrector pill m uscle
Blood v e sse ls  
S w eat g lands 
F ree nerve endings
Lymphatic channels
Nerve fibres
P acinian  corpuscu les
Figure 1.3. The structure of skin with details of receptor localisation.
From Dermatology Information Service Department o f  Clinical Social M edicine, University o f  
Heidelberg.
(downloaded from http://skincancer.derm is.net/content/e0lgeninfo/e7/index_eng.htm l)
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1.9. Anatomy of the arm
1.9.1 Muscles of forearm limb
The muscles of the forearm are mostly slender and they have long and narrow 
tendons. The flexor muscles of the anterior forearm are supplied by median or ulnar 
nerve while the more posterior extensors are supplied by the radial nerve. This is 
illustrated in figure 1.4. The muscles of anterior surface of the forearm are best 
described in three layers. The superficial layer comprises pronator teres, flexor carpi 
radialis, palmaris longus and flexor cai'pi ulnaris. Flexor digitorum superficialis 
comprises the intermediate layer and the deep layer comprises flexor pollicis longus, 
flexor digitorm profundus and pronator quadratus.
1.9.2. Dermatomes of the upper limb
Dermatomes bear a close topological relationship to spinal segments as illustrated in 
figure 1.5. For example, the median nerve is a mixed nerve that originates from the 
C6 to T1 spinal nerve roots and the lateral and medial cords of the brachial plexus. It 
supplies mainly the anterior compaitment of the forearm and the thenar muscle 
group. It carries cutaneous sensation from the lateral two thirds of the anterior aspect 
of the palm and the lateral 3 fingers, including the dorsal surface of the terminal 
phalanges. The C7 nerve root supplies cutaneous sensation of the middle finger.
The cutaneous sensation of the index and the thumb is in C6 or C7 nerve roots. The 
median nerves gives rise to a pure motor branch called the anterior interosseous 
nerve that supplies the anterior forearm muscles.
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Mypothenar muscles
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Midial tpioondyi. of humoni»
Ulnar norvo 
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F1.xor carpi ulnaris muscl.
Bitwisor caipi ulnaris muscl.
B(t.nsor digkl minimi muscl*
BriMsor ratinaoulum 
(comparimwris numbw.d)
DorsX branch of ulnar nwv 
Brionsor caipi ulnaris tondon 
Ext.nsor dig* minimi 
Brimsor digkonim twdons
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BrtMtsof digkotum muscl.
let or poKcis longus muscl. 
BctMTSor pollicis brevis muscl. 
BrtMSor policis longus tendon
Brtwsor carpi radialis brevis tMtdon 
Brtwisor carpi radialis longus tendon 
Supwficial branch of radiai n « v .  
Abductor poXcis longus tvtdon 
Brtensor poWois bra vis tendon 
Anatomical snuffbox
Bctwsor policis longus tmdon 
Brtwisor indicis twxlon
Figure 1.4. Illustration of the positions of the forearm muscles.
The upper panel shows an anterior view and the lower panel shows a posterior view . Interactive Atlas 
o f Human Anatomy by Frank H. Netter. Published by Ciba Medical Education.
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The ulnar nerve originates from the C8 and T 1 spinal roots. It innervates the flexor 
carpi ulnaris muscles, the hypothenar muscle groups, palmar and dorsal interossei 
muscles, and the deep head of the flexor policis brevis, as well as the adductor 
pollicis muscle. It supplies the cutaneous sensation of the medial side of the hand 
over the hypothenar muscle group.
The radial nerve is derived from the C5, C6, C7, C8 and T 1 spinal nerve roots and 
the posterior cord of the brachial plexus. The motor branches of the radial nerve 
motor innervate the triceps brachii, anconeus, brachioradialis, extensor carpi radialis 
longus, and brevis, as well as the posterior compartment of the forearm. The sensory 
branch of the radial nerve arises from the C6, Cl roots and supplies the lateral aspect 
of the back of the hand (Nalty and Sabbahi, 2001).
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C3
C4
C7
C8
C6
C7
C8
Figure 1.5. The upper limb surface and their relation to spinal cord segments.
This figure show s the upper limb surface and its relation to spinal cord segm ents, as indicated by 
numbered letter, C, cervical; T, thoracic. (Interactive Atlas o f  Human Anatomy by Frank H. Netter. 
Published by Ciba Medical Education
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1.10. Aims of investigation
The present study will address four main questions about the effect of topical 
anaesthesia on hand tremor:
1. Is there any difference in physiological tremor at rest in normal subjects after the 
application of a placebo and a xylocaine spray?
2. Is there a difference in muscle activity of the forearm at rest after application of a 
placebo and xylocaine spray?
3. Does any difference in physiological tremor during movement in normal subject 
after application of placebo and xylocaine spray?
4. Is there a difference in pathological tremor at rest after application of a placebo 
spray and xylocaine?
4 1
Chapter 2 
General Methods and Materials
This chapter provides details of the materials and methods that were used in several 
experiments. Materials and methods specific to particular experiments will be 
described in the appropriate chapter.
2.1. Volunteers
Thirty-six adult volunteers, both male and female, participated in these experiments. 
They had no history of neurological disease or muscular disorders. Their mean age 
was 28 years. All subjects gave their informed consent in accordance with the 
protocol approved by the Glasgow University Research Ethics Committee. They 
were free to withdraw from the experiment at any stage. None of the subjects 
withdrew from the experiments. Neither did they report any kind of discomfort 
during the tests. Each volunteer made two visits to the laboratory. Each visit lasted 
approximately one hour. During the first visit, the nature of the experiment was 
explained, consent was obtained and the volunteer was familiarised with the 
experiment. The last part of this visit consisted of the first recording session. This 
was done with either a local anaesthetic or a placebo spray applied to their skin. On 
the second visit the other spray was used. The sequence of placebo local anaesthetic 
was randomised by asking the volunteer to select a sealed envelope containing the 
sequence of sprays.
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2.2. Experimental set up
The general experimental set up is shown in figure 2.1. Each volunteer was seated 
comfortably in a chair. Their forearm was extended and supported by a frame. Their 
fingers, hand and wrist joint were free to move. Surface eleetromyograms were 
recorded from Flexor Carpi Radialis and Extensor Carpi Radialis muscles. A biaxial 
accelerometer was attached to the distal end of middle finger to record flexion- 
extension and lateral - medial deviation of the hand.
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Accelerometer 
device
EMG electrode on 
extensor muscles
EMG.electrode on 
flexor muscles
Figure 2.1. The general experimental set up for the first series of experiments. 
The instrument shown include:
1. two EMG electrodes and amplifiers, which were placed 2-3cm  below  the elbow  joint.
2. a biaxial accelerometer attached at the end o f middle finger,
3. the Neurolog isolator unit, EMG amplifier, a CED 1401 interface unit and PC.
Notice the subject’s arm is supported leaving the hand and wrist joints free to move.
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2.3.1. Electromyography Recording
Two electromyography-recording systems were used. The first system, described in 
section 2.4.1, was used in the experiments described in chapter 4. The second system 
described in section 2.4.2 was used in the experiments reported in chapter 5.
2.4.1. EMG Recording System 1
Two identical EMG recording channels were used. Each used small, skin mounted 
EMG pre-amplifiers with integrated electrodes. These are shown in figure 2.2. The 
amplifier weighed 13.4 grams. The electrode discs were 7 mm in diameter and they 
were separated by 20 mm. This device eliminated connecting wires and so movement 
artefacts were kept to minimum. The EMG signal was pre-amplified by xlOO. The 
amplifier bandwidth was -3  dB at 10 Hz to 5 kHz. The EMG signals were then 
passed to a Neurolog NL 820 isolator amplifier whose gain was xIO. The signal was 
subsequently conditioned with a Neurolog NL 106 AC/DC with a gain of 1. Any DC 
offset was removed before the EMG was digitised.
2.4.2 EMG Recording System 2
In the experiments described in chapter 5 and the case studies, a commercial 
Neurolog system was used to record two channels of EMG. An earth strap 2 cm 
broad was fastened round the upper arm with Velcro. Two silver/silver chloride discs 
9 mm in diameter were taped over the muscle belly. The electrodes were separated 
by 20 mm. The electrodes were connected to an NL 822 amplifier. Its gain was set at 
xlOOO and it had a high pass filter set at 3 Hz. The EMG signal was passed to a NL
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820 isolator unit with a gain o f x 1. The EMG signals were then digitised by the CED 
1401.
Figure 2.2. Several small items of experimental equipment.
An electrogoniom eter is shown top left. An Analog D evices ADXL 210E biaxial accelerometer is 
shown top right. The V elcro earth strap is shown in the lower right position. In the middle left position 
is an integrated EMG electrode/am plifier and on the bottom left is a pair o f  silver/silver chlorides 
electrodes.
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2.5. Accelerometers
An ADXL210E accelerometer (Analog Devices, Leeds, United Kingdom) was used. 
This is a very small two-axis accelerometer with mounted on an integrated circuit 
with its associated amplifiers. The total dimension of the chip was 5 mm x 5 mm x 2 
mm. Its operating range was + lOg. It is robust and it can survive a transient shock of 
lOOOg. It is designed to measure both dynamic accelerations e.g. vibration as well as 
static acceleration e.g. gravity. The manufactures specification sheet reports an 
interaction between the two axes of at most 2%. The accelerometer was supplied 
with a DC excitation voltage of 4.5 volts. The output from each channel was 
connected to the Neurolog system NL 106 AC/DC amplifier with gain xlO to remove 
offset DC before being digitised by the CED 1401. The output of both accelerometer 
channels after amplification was 80 millivolts equal to 1 metre/second/second.
2.6. Digitisation
All signals were digitised by CED 1401 Micro II interface (CED Ltd; Cambridge, 
England). The EMG and acceleration signals were digitised at 1024 Hz and stored in 
a PC. Spike 2 software, version 3.15, was used to process the signals.
2.7. Recording Protocol
During a typical experiment recording session, the subject was asked to hold a fixed 
position or make small movements for a period whilst the EMG and accelerometer 
outputs were recorded simultaneously. These recording episodes lasted 20-60 
seconds. In general several short episodes were recorded close together of 4 periods
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of 20 seconds. There was then an interval o f up to 15 minutes before a subsequent 
recording episode. Figures 2.3a/b show typical recordings.
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Figure 2.3.a. Specimen recording hand tremor at rest in normal subject for a period 
of 20 seconds.
These data were recorded in a neurologically normal volunteer. The top two traces show the output 
signals o f  the accelerometer. A ccel X: show s acceleration in the x- plane. This is the lateral/medial 
plane. A ccel Y; show s acceleration in the y-plane. This is the anterior/ posterior plane.
The lower two traces show the surface eleetrom yogram s. EMG 1 : electromyogram is recorded from 
Extensor Carpi Radialis muscles forearm extensor muscles group. EMG2: electromyogram is 
recorded from Flexor carpi Radialis m uscles. Forearm tlexor group.
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f  1 
metre/seco nd/second.
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Figure 2.3.b. Recordings of hand tremor from a normal subject over a period of 2 
minutes.
The volunteer maintains a stationary position o f  the hand, supporting it against gravity lor the first 60  
seconds and then the volunteer tracks a sine wave. The top two traces wave show:
Gonio : channel 6 illustrates the movement o f  flexion-extension by goniometer. The initial 60  
seconds show s the wrist in a neutral position at 180 degrees. It is then follow ed by flexion o f 40  
degrees and then to 30 degrees o f  extension.
Sine: sine wave in channel 5 is a guide to control movement o f  the volunteer.
The peak-peak magnitude o f  the movement is from neutral position o f  the hand to full flexion o f  the 
wrist and extension to the neutral position.
Channels 1-4 are as described in figure 2.3a. The lower traces show the surface electromyogram. 
EMG 1 is recorded from forearm extensor and EMG2 is recorded from forearm flexor group muscles.
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f  1 
metre/second/second.
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2.8. Analysis
Interesting sections of each data were identified using vertical cursors. Spike 2 was 
then used to calculate a power spectrum from this section of the trace.
2.8.1. Accelerometer power spectrum analysis
Power spectra based on 1024 points were calculated. A typical example is shown in 
figure 2.4. The energy concentration in three defined frequency ranges were 
measured. These were 2-6 Hz, 6-12 Hz and 12-20 Hz. The area of the spectra to be 
measured were specified with 4 cursors. The area of the spectrum between each 
cursor were measured. The data was transferred to text file and subsequently saved 
as Excel files.
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Figure 2.4. Typical spectra for postural tremor in a normal volunteer.
The top panel shows the spectrum o f  y-axis tremor in the flexion/extension plane and the lower panel 
shows x-axis tremor in the medial/lateral plane. They were recorded at the same time.
The tremor energy is expressed as volts".
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Windowing of data
The experiments were performed over a period of two years. The data in chapter 3 
were recorded and processed using spike 2, version 3.15. The data in chapters 4 and 
5 were recorded and processed in spike 2 version 5.03. The later version allows 
windowing of the data. This improves the resolution of the spectra and the author 
wished to investigate how windowing might affect the data in chapter 3.
A brief comparison of data was made without any widowing and with Hanning or 
Hamnoing windowing. The results of the same data processed without and with 
windowing are shown in figure 2.5. These show that the effects of windowing are 
relatively minor in this case and that the simpler data processing in chapter 3 did not 
degrade the spectra significantly.
No window
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Figure 2.5. Windowing of data.
This show s a frequency spectrum o f  y axis (flexion/extension) tremor at rest in one normal subject 
calculated without windowing the data in on the top panel, with a Hanning window in the middle 
panel and with a Hamming window in the bottom panel.
The tremor energy is expressed as volts^.
It show s no significant difference in the spectra.
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2.8.2. EMG Analysis
The EMG signals recorded in these experiments were typically low amplitude. They 
were subjected to a bandstop digital filter centred at 50 Hz with a filter width 
transition gap of 7.4 Hz. Whilst this was successful in removing the contribution of 
the mains frequency artefact to the EMG signal it also removed part of the EMG 
spectrum. The filtering had a significant effect on the EMG signal. If the filter was 
not used the low level EMG would be distorted by the 50 Hz component contributed 
by the mains supply. It was considered best to filter the signals and then compare all 
the signals after they had been processed in the same way.
The root mean square value of the EMG signal after filtering was calculated using 
Spike 2. These data were transferred to text files and ultimately saved as Excel files.
2 ,9, Statistical analysis
The advice of the Robertson Centre for Biostatistics at Glasgow University was 
sought and followed.
Various features of the electromyogram and accelerometer signals were measured. 
For each volunteer several the features were measured: for example, the RMS EMG 
or area within a frequency range of the tremor spectrum and the mean of the four 
episodes was calculated. After two visits to the laboratory each volunteer then had a 
mean value for that feature in the two experimental conditions. The difference in the 
two means was calculated for all volunteers and this allowed a confidence interval of 
the mean difference to be calculated. The result was deemed to be significant if the 
95% confidence interval did not include zero.
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2.10. Application of sprays to the skin
2.10.1. Xylocaine
A spray of 10% Xylocaine, manufactured by Astra Zeneca UK Ltd., was used. This 
Xylocaine spray contains ethanol, methanol natural, polyethylene glycol 400, 
essence of banana, saccharin and purified water. It was applied to the skin of the 
upper limb (all of the arm and forearm except for extensor forearm and the hand). 
After spraying a little massage made sure the whole area was covered.
2.10.2. Placebo
A placebo spray was made up to match the colour, viscosity and packaging of the 
Xylocaine spray. It was applied to the same skin areas, as the Xylocaine with the 
same technique.
The volunteers were unaware as to whether a Xylocaine or a placebo spray had been 
applied to their skin.
2.11. Electrogoniometer Recording
In the experiments described in chapter 4 the volunteers were asked to make 
sinusoidal movements of their wrist. A sinusoid was displayed to the volunteer on 
an oscilloscope screen and they tracked this with their movement. This is illustrated 
in figure 2.3b. A Feedback PFG605 Function Generator (Electroplan, Royston, UK) 
was used to generate low frequency sinusoidal signals at 0.1 -  0.5 Hz. These were
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displayed on an oscilloscope to allow the volunteer to control the speed of 
movement at the wrist. The output of the function generator was also digitised and 
stored.
The wrist movement was detected by a twin axis goniometer (SG65 Biometrics 
Ltd., Gwent, UK), which was taped to the dorsum of the hand. The distal end block 
to the dorsal surface over the third metacarpal was measured with the centre axis of 
hand. The proximal end block was placed distally on the dorsal forearm near the 
wrist. Only one axis was used to track the movement. The goniometer measured a 
range of angular movement of + 60 degrees. It weighed 15 grams and did not 
interfere with the free movement of the wrist. The goniometer signal was amplified 
and its output was digitised at 100 Hz by the CED 1401.
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Chapter 3 
Effect of xylocaine on postural tremor in the hand
3.1 Introduction
Topical anaesthesia of areas of skin covering the upper and lower limbs has been 
used successfully to enhance the rehabilitation of patients affected with stroke, head 
injury and familial spino-cerebellar degeneration (Sabbahi, 1987). The active and 
passive range of movement of the upper and lower limb joints showed a substantial 
increase after anaesthesia (Sabbahi, Roy, De Luca and Van Volkinburg, 1984). The 
speed and range of movement of upper limbs during reaching, raising the arm above 
the head, abduction, flexion movements of the arm and handling tasks all improved 
after topical anaesthesia. In the lower limbs, the range of movement at the ankle and 
knee also improved after topical anaesthesia (Sabbahi, De Luca and Powers, 1981). 
Patients without soft tissue contractures showed a greater increase in the active range 
of movement after anaesthesia. In addition, there was improvement in the gait of 
hemiparetic patients and several patients went on to walk without canes (Sabbahi, De 
Luca and Johnson, 1982). The authors reported that the extent of functional 
improvement during the treatment programme varied. Furthermore, patients with 
normal cutaneous sensation to superficial touch showed more variable responses 
following topical anaesthesia. The action of the local anaesthetic is thought to be 
confined to the skin. Sabbahi and De Luca (1982) did not find any trace of local 
anaesthetic in the bloodstream during their experiments.
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Topical application of local anaesthetic to most areas of skin of the lower limb has 
been shown to reduce significantly the amplitude of physiological action tremor at 
the ankle and pathological clonus (Pozos, Mills and laizzo, 1984; Mills and Pozos, 
1985). The one exception to this is that topical anaesthesia of the skin over anterior 
tibialis had no effect on ankle tremor (Pozos et al., 1984).
Topical anaesthesia has also been studied as an adjunct to treatment with propanolol 
for the suppression of essential tremor on hand tremor (Pozos and laizzo 1992). The 
combined treatment significantly reduced the amplitudes of tremor accelerations and 
eleetromyograms.
The present study was designed to investigate the effect of topical anaesthesia by 
10% xylocaine on physiological tremor of the hand in normal subjects.
3.2 Aims
The aims of the study were:
1. To investigate the frequency spectrum of hand accelerations before and after 
application of topical anaesthesia.
2. To investigate the surface electromyogram of flexor and extensor muscle groups in 
the forearm before and after application of topical anaesthesia.
3. To investigate if the tremor changes are associated with changes of muscle 
activation.
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3.3 Methods and Materials
3.3.1 Volunteers
Nineteen adult volunteers, both male and female, participated in these experiments. 
They had no history of neurological disease or muscular disorders. Their mean age 
was 28 years. All subjects gave their informed consent in accordance with the 
protocol approved by the Glasgow University Research Ethics Committee. They 
were free to withdraw from the experiment at any stage. None of the subjects 
withdrew from the experiments. They did not report any kind of discomfort during 
the tests. Each volunteer made two visits to the laboratory. Each visit lasted 
approximately one hour. The nature of the experiment was explained during the first 
visit and informed consent was obtained. The volunteer then participated in the first 
recording session. This was done with either a local anaesthetic or a placebo spray 
applied to their skin. On the second visit the other spray was used. The sequence of 
placebo or local anaesthetic was randomised by asking each volunteer to select a 
sealed envelope containing the sequence of sprays.
3.3.2 Experimental set up
The general experimental set up was described earlier in section 2.2 and shown in 
figure 2.1.
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3.3.3 Position of forearm
The subject’s forearm was extended horizontally in the prone position and 
supported by a frame. The fingers, hand and wrist joint were free to move.
3.3.4 Position of EMGs recording electrodes
In this experiment two small skins mounted EMG amplifiers with integrated 
electrodes were used. These are shown in figure 2.2. One amplifier was placed on the 
posterior forearm over Extensor Carpi Radialis some 2-3 cm below the elbow joint 
space. A second EMG amplifier was placed over the Flexor Carpi Radialis. The 
position of recording amplifiers is shown in figure 2.1. of the General Methods 
chapter.
3.3.5 Recording Protocol
The subject extended their right hand horizontally in the prone position. The forearm 
was supported except for the hand. The wrist joint was free to move. The tremor was 
recorded in four episodes each lasting 20 seconds. Surface electromyograms and x- 
axis (lateral/medial deviation of hand) and y-axis (flexion/extension of hand) 
acceleration were recorded simultaneously. Typical recording episodes are shown in 
figure 3.1.
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33.6 Power spectra at rest
Figure 3.2 shows power spectra for one volunteer. They were calculated from a 20- 
second recording taken 30 minutes after the application of xylocaine spray (right 
panel) or placebo spray (left panels). The upper pair of spectra shows the spectra of 
y-axis tremor and the lower pair shows x-axis tremor. All of the spectra show a peak 
at about 10 Hz but the magnitude of this is different in each case.
3.4 Results
The mean energy in each frequency range was calculated as described in figure 3.3. 
The difference in means was calculated for each person. The difference in mean for 
all nineteen volunteers was then used to calculate a confidence interval. The staff of 
the Robertson Centre for Biostatistics recommended this method of analysis. In 
summary, if the confidence interval contains zero, there are no significant differences 
between the effects of the placebo and the local anaesthetic.
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Figure 3.1. Recordings for 20 seconds of postural tremor of the hand tremor in 
normal subject.
The top panel was recording 30 minutes after application o f  xylocaine spray. The lower panel was 30  
minutes after the application o f  the placebo spray. The panel shows recordings o f  surface EMG from 
Extensor Carpi Radialis (EM G l ) and Flexor Carpi Radialis (EM G2) and tremor in a lateral /medial 
plane (A ccel X ) and anterior posterior plane (A ccel Y).
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f  1 
metre/second/second.
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Figure 3.2. Power spectra for x and y-axis tremor in normal subject at rest.
The left panels show results obtained 30 minutes after the application o f  the placebo. The right panels 
show s results obtained 30 minutes after application o f  a 10% xylocaine spray.
Y -axis is flexion/extension tremor and X -axis medial/ lateral tremor. Power spectra based on 1024 
points were calculated for 20 seconds data samples.
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Subject X
Placebo at time 0 min Xylocaine at time Omin
Episode 1 ^ Spectrum 1 Episode 1 ^Spectrum  1
Episode 2 ^  Spectmm 2 Episode 2 ^Spectrum  2
Episode 3 ^  Spectrum 3 Episode 3 ^Spectrum  3
Episode 4 ^  Spectrum 4 Episode 4 ^Spectrum  4
Mean spectra placebo Mean spectra Xylocaine
Placebo mean spectrum - Xylocaine mean spectrum
Difference subject X at time 0
Subject Difference 0 min
A difference
B difference
C difference
D difference
E difference
difference
difference
difference
difference
N difference
Mean differences of nineteen subjects
Standard deviation
Confidence interval
Confidence interval of nineteen subjects
at 0 minutes
Figure 3.3. The calculation of confidence intervals.
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3.4.1 Y-axis tremor after the application of xylocaine or placebo sprays
Table 3.1 contains a summary of the mean differences of y-axis tremor spectra 
(placebo - xylocaine) and confidence intervals. A separate set of data is shown for 
each of the three frequency bands studied, 2-6 Hz, 6-12 Hz, and 12-20 Hz. An 
analysis is also shown for the whole tremor band 2-20 Hz.
The top panel in table 3.1 shows the mean differences in y-axis tremor at the start of 
the two experiments. This is before the application of the placebo or xylocaine spray. 
No significant difference is observed. This is an encouraging finding since it means 
that resting tremor must have been similar in the volunteers on the two days of 
testing.
However, the subsequent measurements at 15, 30, 45 and 60 minute intervals after 
the application of the spray also show no significant differences. The mean 
differences are consistently negative in all frequency bands between 15 and 60 
minutes, except for the 2-6 Hz band at 30 minutes. Given the way the mean 
difference is calculated, this must mean that the tremor contained more energy after 
the xylocaine spray than after the placebo spray. Even with this consistent small 
change the result did not achieve statistical significance.
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Time
Frequency
Band
Mean
Difference
Confidence Interval
0 min 2-6 Hz 0.35 -0.22 0.91 ns
6-12 Hz 0.00 -2.02 2.01 ns
12-20 Hz 0.07 -0.02 0.16 ns
2-20 Hz 0.42 -2.25 3.08 ns
15 min 2-6 Hz -0.14 -1.22 0.94 ns
6-12 Hz -1.06 -3.19 1.08 ns
12-20 Hz -0.11 -0.28 0.07 ns
2-20 Hz -1.30 -4.69 2.08 ns
30 min 2-6 Hz 0.59 -0.39 1.57 ns
6-12 Hz -0.66 -2.24 0.91 ns
12-20 Hz -0.08 -0.19 0.03 ns
2-20 Hz -0.15 -2.82 2.51 ns
45 min 2-6 Hz -0.03 -1.03 0.97 ns
6-12 Hz -0.12 -1.18 0.95 ns
12-20 Hz -0.09 -0.22 0.05 ns
2-20 Hz -0.23 -2.43 1.97 ns
60 min 2-6 Hz -0.47 -1.33 0.38 ns
6-12 Hz -0.97 -2.31 0.37 ns
12-20 Hz -0.32 -0.71 0.07 ns
2-20 Hz -1.76 -4.35 0.82 ns
Table 3.1. The mean differences between y-axis tremor spectra (placebo -xylocaine) 
for nineteen volunteers.
Data are presented for four-frequency ranges and at intervals up to 60 minutes after application o f  the 
spray. The confidence intervals are also show s for each case. All the intervals contain zero and so it 
can be concluded that no significant difference exists between the application o f  xylocaine and the 
placebo.
Each value in the table is multiplied by 10  ^ for clarity.
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No. Subjects 0 min 15 min 30 min 45 min 60 min
1 7.39 4.20 5.13 4.28 5.51
2 22.81 22.19 15.15 14.09 17.21
3 4.76 7.12 7.51 6.29 7.56
4 6.57 4.79 4.34 3.63 4.83
5 10.09 14.59 8.60 7.37 6.47
6 4.54 4.35 4.81 5.19 4.77
7 7.51 4.64 4.68 6.62 4.80
8 4.67 3.90 3.56 3.97 5.40
9 18.11 18.57 15.75 12.40 10.94
10 7.92 4.35 6.07 5.43 5.44
11 6.21 6.04 4.66 4.34 5.22
12 5.10 4.52 5.29 5.83 6.46
13 3.88 4.43 4.46 4.32 4.41
14 6.86 6.80 5.83 4.35 4.72
15 14.80 14.48 17.33 12.12 7.51
16 10.98 18.23 17.66 13.21 12.84
17 12.43 9.45 6.68 10.92 9.84
18 7.76 14.04 10.42 8.36 25.80
19 12.02 15.57 7.15 8.32 4.25
Table 3.2. Effect of topical anaesthesia on y-axis postural tremor for 19 subjects.
Tremor energy in the frequency range 2-20 Hz at intervals up to 60 minutes after application o f  
xylocaine spray. Each value in the table has been multiplied by 10  ^ for clarity.
Subjects 2, 9, 15, and 17 show high tremor energy before the xylocaine application Their tremor is 
subsequently reduced. Subjects 3, 16 and 18 have low  initial tremor energy which increases after 
xylocaine application. However, it can concluded that there are no significant changes in tremor after 
xylocaine application (P = 0.678, A N O V A ).
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No. Subjects 0 min 15 min 30 min 45 min 60 min
1 6.56 4.52 5.29 5.24 4.07
2 11.23 10.89 12.88 14.19 12.12
3 6.12 6.04 4.28 3.79 3.45
4 3.97 4.54 11.88 4.67 4.57
5 17.22 24.44 12.69 11.30 6.51
6 9.37 4.99 4.21 3.31 4.88
7 6.58 9.83 7.46 6.67 4.62
8 5.52 4.50 5.74 3.88 4.14
9 18.28 12.52 9.58 9.33 10.94
10 7.00 9.96 7.79 7.68 8.03
11 6.13 8.00 4.53 2.47 5.64
12 4.69 3.40 7.11 6.91 5.91
13 6.44 4.41 5.48 5.02 5.21
14 4.26 3.47 5.33 3.89 3.51
15 13.92 11.35 8.10 6.31 4.38
16 10.51 6.61 9.06 8.39 6.99
17 8.02 8.09 7.77 8.84 7.00
18 12.16 9.36 9.38 15.49 8.78
19 22.48 11.68 12.64 9.05 7.78
Table 3.3. Effect of placebo spray on y-axis postural tremor for 19 subjects.
Tremor energy in the frequency range 2-20 Hz at intervals up to 60 minutes after application o f  
xylocaine spray. Each value in the table has been multiplied by 10  ^ for clarity.
Subjects 19 show s a strong initial tremor which decreases after the placebo spray . Subjects 3 and 16 
show low  initial tremor which decreases further after placebo.
However, it can concluded that no significant changes in postural tremor occur after the application o f  
the placebo spray (P = 0 .134, A N O V A ).
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Figure 3.4a, b. Effects o f xylocaine and placebo sprays on y-axis tremor energy in 
the frequency band 2-20 Hz.
The upper figure (A ) show s effect o f  xylocaine on y-axis tremor in 19 volunteers. The lower figure 
(B) shows tremor after placebo spray in the satne volunteers.
The volunteers with higher energy tremor show s reductions o f tremor after the application o f  
xylocaine or placebo sprays. The volunteers with lower energy tremor show less change after the 
xylocaine or placebo spray.
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Table 3.4 shows the means and standard deviations of the resting Y-axis tremor 
energy in 19 neurologically normal volunteers. Data representing the tremor 
amplitude before and after the application of a placebo (P) or topical anaesthetic 
(TA) spray are presented. The table shows details of tremor in three frequency bands: 
2-6 Hz, 6-12 Hz, 12-20 Hz and for the whole tremor band 2-20 Hz.
The Y-axis tremor energy was measured at five time points between 0 minute and 
60 minutes after the application of the spray. Figure 3.5 shows graphs of these data. 
The top panel, figure 3.5A shows the mean Y-axis tremor for the 2-20 Hz band in 
each condition. The lower panel, figure 3.5B shows bar charts of the means and 
standard deviations.
There was no statistically significant change in the tremor over the period of the 
experiment. The data were subjected to an ANOVA test using the General Linear 
Model in Minitab version 13. This gave values of p = 0.679 for the tremor after 
xylocaine application and p = 0.134 for the tremor after the placebo application.
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Time
Frequency
Band
Mean
P
SD
P
Mean
TA
SD
TA
0 min
2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
4.26
4.67
0.57
9.50
1.29
4.37
0.38
6.04
3.91
4.68
0.50
9.08
1.11
4.45
0.32
5.88
15 min 2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
4.04
3.92
0.39
8.35
1.72
4.39
0.26
6.37
4.18
4.98
0.49
9.65
2.10
5.31
0.42
7.83
30 min 2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
4.47
3.18
0.30
7.96
2.11
2.56
0.10
4.78
3.88
3.84
0.39
8.11
1.26
4.21
0.30
5.76
45 min 2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
3.94
2.94 
0.30 
7.18
1.83
2.41
0.23
4.47
3.97
3.05
0.39
7.41
1.72
2.85
0.32
4.90
60 min 2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
3.66
2.42
0.26
6.34
1.49
1.57
0.16
3.22
4.13
3.39
0.58
8.10
1.49
3.98
0.89
6.36
Table 3.4. The mean and standard deviations of y-axis tremor energy after placebo 
and topical anaesthesia for nineteen volunteers.
Data are presented for four-liequency ranges and at intervals up to 60 minutes after the application o f  
the spray. The main and standard deviations are also show s for each case. The top panel shows the 
mean and standard deviation in Y -axis tremor at rest tremor at the start o f  the two experimental 
sessions. This is before the application o f  sprays. The values are show s that not statistically significant 
change over the 5 periods o f  measurement when tested with an A N O V A  (P = 0.134) at 2-20 Hz. The 
changes after xylocaine were also not significant (P = 0.679). Each value in the table has been 
multiplied by 10  ^for clarity.
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Figure 3.5. Mean and standard deviation of the y-axis postural tremor after 
application of either a placebo or a topical anaesthesia spray.
Data is shown for tremor energy in a frequency band o f  2-20 Hz in nineteen subjects. The tremor 
energy is expressed as volts^.
Panel A show s the mean values for the trials with xylocaine and placebo applications. Panel B shows 
a bar chart showing means and standard deviations.
There are no significant changes over the 60 minutes. See legend o f  table 3.4 for statistics.
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3.4.2. X- axis tremor after the application of xylocaine or placebo sprays
The x-axis tremor was recorded from the same volunteers at the same time as the y- 
axis tremor. These acceleration signals were processed in the same way. The 
summary data are shown in table 3.5.
The result is very similar to that described previously for the y-axis tremor. The 
mean difference is not significant in any of the frequency bands at any of the times 
tested except for the 6-12 Hz band at 60 minutes. This is probably a chance 
observation. The mean differences are consistently negative, except for the lowest 
frequency band 2-6 Hz and 2-20 Hz at 30 minutes and at zero time in frequency band 
2-6 Hz and 6-12 Hz. The only positive difference occurs at 30 minutes in the 
frequency band 2-6 Hz.
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Time Frequency
Band
Mean
Difference
Confidence interval
0 min 2 - 6  Hz 0.12 -0.43 0.67 ns
6 -12  Hz 0.01 -0.40 0.42 ns
1 2 -2 0  Hz -0.22 -0.55 0.10 ns
2 - 20 Hz -0.09 -1.78 1.19 ns
15 min 2 - 6  Hz -0.19 -1.04 0.66 ns
6-12  Hz -0.40 -0.92 0.11 ns
12 - 20 Hz -0.19 -0.38 0.01 ns
2 - 20 Hz -0.78 -2.34 0.78 ns
30 min 2 - 6  Hz 0.33 -0.70 1.36 ns
6-12  Hz -0.19 -0.71 0.33 ns
12 - 20 Hz -0.06 -0.35 0.23 ns
2 - 20 Hz 0.08 -1.76 1.92 ns
45 min 2 - 6  Hz -0.29 -1.25 0.66 ns
6-12  Hz -0.14 -0.41 0.12 ns
1 2 -2 0  Hz -0.04 -0.15 0.06 ns
2 - 20 Hz -0.48 -1.81 0.85 ns
60 min 2 - 6 H z -0.60 -1.39 0.20 ns
6-12  Hz -0.39 -0.76 -0.01 s
1 2 - 2 0  Hz -0.09 -0.26 0.08 ns
2 - 20 Hz -1.07 -2.41 0.27 ns
Table 3.5 The mean differences between x-axis tremor spectra (placebo-xylocaine) 
for nineteen volunteers.
Data are presented for four-frequency ranges and at intervals up to 60 minutes after the application o f  
the sprays. The confidence intervals are also shown for each case. All the intervals contain zero except 
for 60 minutes at 6-12 Hz.
It can be concluded that no significant difference exists between the application o f  xylocaine and the 
placebo. Each value in the table has been multiplied by lO*" for clarity.
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No. Subjects 0 min 15 min 30 min 45 min 60 min
1 5.45 3.39 4.56 3.62 5.11
2 11.63 10.55 9.33 11.10 5.97
3 3.65 6.14 6.76 5.59 6.29
4 5.85 4.21 3.52 4.71 4.37
5 7.85 9.29 6.07 5.91 6.83
6 4.36 3.64 3.93 4.56 4.02
7 5.44 3.60 4.01 5.40 3.55
8 5.15 4.93 4.06 4.50 5.23
9 8.74 9.90 9.75 8.68 9.03
10 5.55 5.85 5.18 4.09 5.74
11 5.15 4.99 3.88 4.05 4.51
12 9.75 10.15 9.63 9.10 13.47
13 4.62 4.45 4.45 4.66 3.88
14 4.41 5.92 5.64 3.95 4.46
15 10.38 12.82 10.11 6.67 6.89
16 5.04 4.55 6.44 3.82 4.80
17 7.94 7.08 5.02 8.02 6.75
18 5.78 4.04 4.66 3.40 3.97
19 6.70 6.80 7.13 7.72 3.01
Table 3.6. The effects of topical anaesthesia on x-axis postural tremor for 19 
subjects.
Data presented the frequency range 2-20 Hz and at interval o f  up to 60 minutes after application of 
xylocaine spray. Each value in the table has been multiplied by lO'’ for clarity.
There is no significant change in x axis postural tremor after the xylocaine spray (P = 0.753, 
AN O V A ).
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No. Subjects 0 min 15 min 30 min 45 min 60 min
1 5.38 3.81 4.20 4.34 3.27
2 8.17 7.00 9.48 9.13 8.32
3 4.39 3.33 4.93 3.49 3.25
4 3.00 3.89 10.97 4.10 3.57
5 8.31 9.28 4.15 5.79 4.84
6 5.30 4.05 3.57 2.80 3.84
7 5.21 6.64 5.43 3.91 3.83
8 6.81 5.18 6.73 3.84 4.40
9 9.35 9.85 6.81 7.24 7.67
10 6.15 9.17 10.49 7.35 6.80
11 4.65 6.59 3.92 2.10 4.55
12 10.94 10.04 7.80 10.14 8.48
13 6.01 4.23 5.11 4.56 4.86
14 3.96 3.34 4.48 3.44 3.46
15 7.57 7.47 7.95 6.45 3.83
16 6.37 4.68 6.29 5.63 4.17
17 6.49 4.63 4.75 4.05 3.39
18 4.46 4.50 4.10 8.26 4.41
19 11.84 6.99 8.23 6.77 4.88
Table 3.7. The effects of placebo spray on x-axis postural tremor for 19 subjects.
Data presented the frequency range 2-20 Hz and at interval up to 60 minutes after application o f  
xylocaine spray. Each value in the table has been multiplied by lO''^  for clarity.
There are no significant changes in postural tremor after the application o f the placebo (P = 0 .118, 
A N O V A ).
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Figure 3.6a, b. Effects o f xylocaine and placebo spray on x- axis tremor at frequency 
2-20 Hz
The upper figure (A ) show s effect o f xylocaine on x-axis tremor. The lower figure (B ) shows tremor 
after placebo spray.
Som e subjects with higher tremor energies show  reduction tremor after the application o f xylocaine or 
placebo spray. Those with lower initial tremor show s no changes after the xylocaine or placebo.
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Table 3.8 shows the mean and standard deviations of the X-axis postural tremor 
energy in the same volunteers. These data were recorded concurrently in the same 
sessions. The structure of the table is similar to 3.2.
The data in the top panel in table 3.4 confirm that the X-axis tremor at rest is the 
same as at the start of the two experimental sessions. The lower panels show the 
tremor characteristics at 15 to 60 minute interval after the application of the sprays. 
There is no significant change in the tremor characteristics in 2-20 Hz band over this 
time after xylocaine (P = 0.753). The changes after placebo application were also not 
significant (P = 0.118). Figure 3.7 shows graphs of these data. The top panel, figure 
3.7A, shows the mean X-axis tremor for the 2-20 Hz band in each condition. The 
lower panel, figure 3.7B, shows bar charts of the means and standard deviations. It is 
clear that there are no significant differences.
78
Frequency Mean SD Mean SD
Time Band P P TA TA
2-6 Hz 3.74 1.03 3.62 0.76
0 min 6-12 Hz 1.85 1.34 1.84 1.35
12-20 Hz 0.79 0.71 1.01 1.08
2-20 Hz 6.38 3.08 6.48 3.19
15 min 2-6 Hz 3.34 1.22 3.52 1.29
6-12 Hz 1.69 1.47 2.10 2.09
12-20 Hz 0.65 0.56 0.84 0.73
2-20 Hz 5.68 3.25 6.46 4.11
30 min 2-6 Hz 3.92 2.04 3.59 1.19
6-12 Hz 1.49 1.08 1.68 1.38
12-20 Hz 0.65 0.54 0.71 0.69
2-20 Hz 6.06 3.66 5.98 3.26
45 min 2-6 Hz 3.36 1.58 3.65 1.62
6-12 Hz 1.34 0.84 1.48 0.91
12-20 Hz 0.57 0.46 0.61 0.48
2-20 Hz 5.26 2.88 5.75 3.00
60 min 2-6 Hz 2.95 1.18 3.54 1.14
6-12 Hz 1.16 0.67 1.54 1.43
12-20 Hz 0.48 0.37 0.57 0.62
2-20 Hz 4.59 2.23 5.66 3.19
Table 3.8. The mean and standard deviation for placebo and topical anaesthesia in X- 
axis tremor spectra for nineteen volunteers.
Data are presented for four-frequency ranges and at intervals up to 60 minutes after application o f  the 
spray. The data in the top panel confirm that the X -axis tremor at rest is the same as at the start o f  the 
two experimental sessions. The lower panels show  the tremor characteristics at 15 to 60  minute 
interval after the application o f  the sprays. In 2-20 Hz band frequency there is no significant change in 
the tremor characteristics after placebo over the 5 period o f measurement when tested with an 
A N O V A  (P = 0.118). The changes after xylocaine were also not significant (P = 0.753). Each value in 
the table has been multiplied by 10® for clarity.
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Figure 3.7 Mean and standard deviation of the x-axis resting tremor after application 
of either a placebo or a topical anaesthetic spray.
Data is shown for tremor energy in a frequency band o f  2-20 Hz in nineteen subjects. The tremor 
energy is expressed as volts^.
Panel A show s the mean values for the trials with xylocaine and placebo applications. Panel B shows 
a bar chart showing means and standard deviations.
It show s no difference before or after application o f either xylocaine or placebo. See the legend o f  
table 3.4 for statistics.
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3.5.1. Effect of xylocaine and placebo sprays on the extensor 
electromyogram
Surface electromyograms were recorded from wrist flexor and extensor groups at the 
same time as the tremor recordings. The electromyograms were filtered to remove 50 
Hz noise and then the root mean square value of the residual signal was calculated. 
The mean differences of RMS electro myogram in the two conditions, after the 
placebo and after the xylocaine sprays, were calculated. The analysis was identical to 
that used for the acceleration signals in tables 3.1 and 3.5.
The top panel in table 3.9 shows the mean differences in the RMS electromyogram 
of the extensor muscles of the forearm at the start of the two experiments. This is 
before the application of the placebo spray or the xylocaine spray. In this case, the 
mean difference is negative and the confidence interval does not contain zero. It can 
be concluded that the RMS value is significantly greater before the application of 
xylocaine than before the application of the placebo spray.
A significant difference also occurs 30 minutes into the experiment. The RMS value 
is greater after the application of the placebo spray. However, no significant 
differences exist at 15, 45 or 60 minutes after the application.
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3.5.2. Effect of the xylocaine and placebo sprays on the flexor 
electromyogram
The flexor electromyogram was recorded from the same volunteers at the same time 
as extensor group electromyogram and the tremor. Table 3.10 shows the mean 
difference in RMS electromyogram for the flexor muscles. In this case no significant 
differences were recorded at any of the times after the application of the spray.
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Time Mean
difference
Confidence Interval
0 min -0.002 -0.004 -9.98E-05 s
15 min -0.001 -0.003 0.001 ns
30 min -0.002 -0.003 -0.001 s
45 min -0.002 -0.004 0.0003 ns
60 min -0.001 -0.003 0.001 ns
Table 3.9. The mean difference in RMS EMG of the wrist extensor muscles after 
placebo and xylocaine application.
The confidence intervals are also shown.
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Time Mean
difference
Confidence Interval
0 mill -0.003 -0.007 0.002 ns
15 min -0.001 -0.003 0.002 ns
30 min -0.001 -0,003 0.0002 ns
45 min 0.001 -0.001 0.002 ns
60 min 0.002 -0.0002 0.004 ns
Table 3.10. The mean difference in RMS EMG of the wrist flexor muscles after 
placebo and xylocaine application.
The confidence intervals are also shown.
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3.6. Discussion
These experiments investigated postural physiological tremor of the hands of 
nineteen normal subjects after the application of a local anaesthetic spray or a 
placebo spray to the skin. The main finding is that there is no significant difference 
in hand tremor during the hour after the application of placebo and the xylocaine. 
Examination of the data in table 3.1 shows that no significant differences exist 
between y - axis tremor spectra after xylocaine and placebo applications in any 
frequency band at any time. Data in table 3.5 show that in 19 of the 20 tests the x- 
axis tremor is not significantly different after xylocaine or placebo application. The 
sole significant result in table 3.5 occurs at 60 minutes after the application in the 
frequency band 6-12 Hz. This is most probably a chance difference.
In both the y-axis and x-axis tremor the mean differences are more frequently 
negative than positive. In the 40 tests there are 8 positive differences and 31 negative 
differences. A positive difference indicates that the tremor is smaller after xylocaine 
than after the placebo. The negative differences suggest that tremor amplitude 
increases after the application of topical anaesthesia.
Overall the results here are in conflict with those in Pozos’ studies (1985 and 1992). 
He reported reduction tremor after topical anaesthesia and this study found no 
change. Pozos and laizzo, (1992) investigated the effect of topical anaesthesia with 
4% xylocaine including propranolol on six cases of essential tremor of the hand. 
They reported significant suppression of hand tremor and muscle activity. An earlier 
study by Pozos and laizzo, (1985) showed that topical anaesthesia reduced 
physiological action tremor at the ankle joint.
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The difference in the result could lie in the selection criteria for the volunteers. Pozos 
investigated the effect of xylocaine on pathological tremor rather than on normal 
physiological tremor. Additionally the disparity between the results of this study and 
Pozos study, may lie in the different areas of skin anaesthetised. The Pozos 
experiments applied 4% xylocaine to the skin over the forearm flexor and extensor 
muscles. In the experiments reported here 10% xylocaine was applied to the whole 
arm except the posterior forearm. It can safely be assumed that 10% xylocaine is at 
least as effective as 4% xylocaine in producing topical anaesthesia. The experiments 
reported here anaesthetised a larger total area of forearm skin. Pozos did anaesthetise 
the posterior forearm skin
In addition, the RMS electromyograms of forearm extensors and flexors are shows in 
tables 3.9. and 3.10. Table 3.10 shows that here are no significant differences in the 
RMS electro myogram of the forearm flexor muscles. However, the RMS 
electromyograms of the extensor muscles do show significant differences. It can be 
seen from table 3.5 that all 5 mean differences are negative and that these reach 
significance twice; at the start of the experiment and at 30 minutes after application 
of the spray that could be relationship between EMG and tremor the extensor 
stiffness and mechanical causes of tremor. The negative difference indicates that the 
EMG is greater after the application of xylocaine than after the application of 
placebo.
Sabbahi, Mason and Gleeson (1985) studied the effect of topical anaesthesia of upper 
limb skin in normal subjects. They reported an increase in the H-reflex amplitude of 
the flexor muscles after topical anaesthesia. The results in this chapter do not show 
any difference in flexor electromyogram. However, the extensor electromyogram
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does show some significant differences. These occur at the start of the experiment 
before any spray was applied and at after 30 minutes. These again are probably 
chance events and they do not relate to any significant changes in the tremors.
However, in the experiments reported here the posterior skin was not anaesthetised. 
The decision to avoid this area was based on the work of Sabbahi et ah, 1985. They 
reported that anaesthesia of this area increased H reflexes in the forearm flexor 
muscles.
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Chapter 4
Effect of xylocaine on tremor in the hand during
movement
4.1. Introduction
The previous chapter described an investigation of the effect of xylocaine on 
physiological tremor at rest. Results were presented which showed no significant 
difference between the application of xylocaine and a placebo spray. This chapter 
will extend the study to investigate the effect of topical anaesthesia on tremor in 
normal volunteers during movement. The oscillations associated with voluntary 
movements can be 2-5 times greater than a physiological recording from the same 
limb (Pozos, laizzo and Petry, 1982 ; laizzo and Pozos, 1992). This phenomenon is 
easy to see in figure 2.3.b. The author wished to investigate the effect of topical skin 
anaesthesia in this larger amplitude movement related tremor.
It has been suggested that all tremors of man may have a common mechanism (Eke- 
Okoro, 1994). Voluntary movements may be associated with rhythmic neural activity 
in human motor cortex (Halliday, Conway, Farmer and Rosenberg, 1998). The B 
rhythm is one component of the cortical rhythms. It has a frequency range of 15-30 
Hz. It is known that phasic voluntary movement is preceded by cortical 
desynchronization mostly in the B-frequency band between 10 and 13 Hz (Feige, 
Kristeva, Rossi, Pizzella and Rossini, 1996; Feige, 1999; Pfurtscheller, 1992;
Salmelin and Harri, 1994). The tremor associated with voluntary contractions is in 
the frequency range (4-12 Hz) and of large amplitude (laizzo and Pozos, 1992).
Often more than one frequency component can be observed in power spectra. All 
these frequencies are associated with voluntary movements.
4.2 Aims
The experiments described in this chapter were performed to investigate the effect of 
topical anaesthesia and placebo application on tremor during movement. The aims of 
this study were to investigate frequency spectrum of hand acceleration during wrist 
movement before and after application of topical anaesthesia.
4.3 Methods and Materials
4.3.1 Volunteers
Twelve adult volunteers, with no history of neurological disease or muscular 
disorder, participated in these experiments. Two men and ten women were tested. 
Their mean age was 28 years. All subjects gave their informed consent in accordance 
with the protocol approved by the Glasgow University Research Ethics Committee. 
They were free to withdraw from the test at any stage. Subjects were tested at two 
sessions. Each session lasted about one hour.
4.3.2 Experimental set up
The general experimental set-up is shown in figure 4.1. A two-axis accelerometer 
was attached to the distal ends of the middle finger of the right hand. (See General
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Methods section 2,5). The x and y axis tremor was digitised and stored on the PC as 
described in General Methods section 2.6. The spectra were calculated in the same 
manner as in the previous chapter.
4.3.3. Electrogoniometer Recordings
An electrogoniometer (SG65, Biometrics Ltd; Gwent, UK) was attached to the 
dorsum of the hand and to the lower part of the forearm to span the wrist. The 
volunteer was asked to make sinusoidal movements of their wrist. A sinusoid was 
displayed to the volunteer on an oscilloscope screen and they tracked this with their 
movement. A Feedback PFG605 Function Generator (Electroplan, Royston, UK) 
was used to generate low frequency sinusoidal signals at 0.1 -  0.5 Hz. These were 
displayed on an oscilloscope to allow the volunteer to control the speed of movement 
at the wrist. The output of the function generator was also digitised and stored. The 
goniometer signal was amplified and the CED 1401 digitised its output at 100 Hz.
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Figure 4.1. The general experimental set up.
The instruments included: a laptop computer and CED 1401 interface unit, a Neurolog system isolator 
unit and a NL 822 amplifier. Tw o EMG electrodes were placed 2 cm below  the elbow  joint with an 
earth strap around the arm. An electrogoniom eter can be seen on the dorsum o f the hand. A biaxial 
accelerometer was attached at the end o f  the middle finger.
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4.4 Results
4.4.1 Tremor in normal subjects during hand movement
Figure 4.2 shows two recordings from a normal subject. Each recording lasts two 
minutes and they were made during two separate recording sessions. The top panel 
was recorded 30 minutes after the application of the placebo spray to the skin of the 
forearm covering the flexor and extensor muscles. The data shown in the lower panel 
were recorded 30 minutes after the application of the xylocaine spray. In each case 
the volunteer maintains a steady position for one minute then begins to make 
sinusoidal flexion/extension movements of their wrist. The onset of movements 
produces a visibly obvious increase in the tremor amplitude.
The increase in tremor in x-axis (lateral/medial deviation of the hand) and y-axis 
tremor (flexion/extension) when movement starts is clearly visible. In addition, the 
change in the electro myogram from forearm flexor group muscles shows a clear 
burst pattern. The changes in extensor EMG are less clear but there is a modulated 
increase.
Figure 4.3 shows power spectra at rest and during movement for one normal subject. 
Tremor power spectra are calculated for 60 seconds at rest and then 60 seconds 
during movement. The top panels show y-axis tremor and the lower panels show x- 
axis. In each pair the left panel shows movement and the right panel shows resting 
tremor. The most obvious difference between the tremor at rest and the tremor during
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movement is that the magnitude of the tremor is much bigger during movement in 
both y and x-axes.
4.4.2 Effect of Xylocaine or the placebo spray on tremor spectra during 
movement
Figure 4.4 shows specimen data from one volunteer. The spectra were calculated for 
one minute of movement, made 30 minutes after the application of the placebo spray 
(left panels) or a topical anaesthetic spray (right panels). There are no obvious 
differences between the Y-axis spectra. The main peak lies at about 8 Hz and the 
amplitudes are similar. The speed of movement of the wrist on both days was 
similar. The volunteers tracked a sine wave at 0.1 or 0.5 Hz. Details of the method 
are given in section 2.11. The x-axis tremor is smaller than the y-axis tremor and 
there are again no obvious changes.
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Figure 4.2. A recording o f tremor during movement by a normal subject.
The upper panel was recorded 30 minutes after application o f  the placebo spray. The lower trace was 
recorded 30 minutes after application o f  the xylocaine spray. The first minute o f  the recording shows 
the volunteer at rest. This is follow ed by a period o f  tracking movements.
The accelerometer calibration for both channels was 80 m illivolts equal to an acceleration o f  1 
metre/second/second.
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Figure 4.3 Power spectra for x and y-axis tremor in a normal subject.
Spectra are calculated for 60 seconds. Y-tremor (flexion extension) during movement and at rest is 
shown in the top pair. The lower pair shows x-axis tremor (medial lateral plane) during movement and 
at rest. The tremor energy is expressed in volts^.
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Figure 4.4. The tremor spectra during movements 30 minutes after the application of 
a xylocaine and placebo spray.
The upper panels show Y -axis tremor (flexion extension) and the lower panels show X -axis tremor 
(medial lateral). The xylocaine spray (right panels) the placebo spray (left panels) recordings were 
made at the same time and power spectra were calculated for recording o f  60 seconds duration.
The tremor energy is expressed in volts^.
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4.4.3 Effects of xylocaine on y-axis tremor during movement
Table 4.1 contains a summary of the mean difference in tremor energy after the 
application of xylocaine and the placebo spray for twelve normal subjects. The 
confidence intervals are also shown. A separate set of data is shown for each of the 
three-frequency bands studied, 2-6 Hz, 6-12 Hz, and 12-20 Hz. The analysis is also 
shown for 2-20 Hz.
The top panel in table 4.1 shows the mean differences in Y-axis tremor at the start of 
the two experiments. This is before the application of the placebo spray or xylocaine 
spray. It shows that the mean difference in y-axis (flexion/extension) tremor is 
consistently positive i.e. tremor after the placebo spray is greater than tremor after 
the xylocaine spray. However, this difference is not statistically significant since the 
confidence intervals contain zero. This was encouraging since it means that 
volunteers began both experiments with similar tremor.
In addition, the results presented elsewhere in table 4.1 show no significant 
differences between application of xylocaine and placebo over one hour. The mean 
differences in all frequency bands are positive at 0 minutes, 15 minutes and negative 
at 30, 45 and 60 minute intervals. These negative values indicate an increase in 
energy after the xylocaine spray than after the placebo spray. None of the results 
showed statistical significance.
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Time Frequency
Band
Mean
Difference
Confidence Interval
0 min 2-6 Hz 0.42 -0.42 0.42 ns
6-12 Hz 0.96 -1.51 3.43 ns
12-20 Hz 0.10 -0.28 0.48 ns
2-20 Hz 1.48 -2.21 4.34 ns
15 min 2-6 Hz 0.05 -0.81 0.91 ns
6-12 Hz 4.72 -3.77 13.20 ns
12-20 Hz 2.63 -2.27 7.53 ns
2-20 Hz 7.40 -6.84 21.64 ns
30 min 2-6 Hz -4.44 -21.72 12.84 ns
6-12 Hz -3.19 -11.82 5.45 ns
12-20 Hz -1.83 -7.32 3.67 ns
2-20 Hz -9.46 -40.87 21.95 ns
45 min 2-6 Hz -0.27 -2.39 1.86 ns
6-12 Hz 0.39 -2.08 2.86 ns
12-20 Hz -0.25 -1.27 0.77 ns
2-20 Hz -0.13 -5.74 5.49 ns
60 min 2-6 Hz -4.89 -14.57 4.80 ns
6-12 Hz -3.74 -11.64 4.16 ns
12-20 Hz -3.31 -10.07 3.45 ns
2-20 Hz -11.94 -36.28 12.41 ns
Table 4.1. The mean difference between y-axis tremor spectra (placebo - xylocaine) 
for twelve volunteers during hand movement.
Data are presented for four frequency ranges and at intervals o f up to 60 minutes after the application 
o f the spray. The confidence intervals are also shown. There is no significant difference between the 
application o f the xylocaine and placebo for each case.
The values o f  the tremor spectrum area have been multiplied by 10*^  to make the values easier to read.
No. Subjects 0 min 15 min 30 min 45 min 60 min
1 7.73 6.44 4.32 4.87 2.88
2 7.50 6.52 4.83 5.49 6.74
3 8.28 11.28 0.68 9.84 5.22
4 23.45 0.60 1.63 6.06 1.51
5 4.50 6.51 7.57 6.66 9.73
6 11.63 9.16 6.37 4.52 5.15
7 8.86 7.94 5.86 5.48 8.04
8 3.31 2.56 2.40 3.07 2.13
9 1.28 1.69 1.65 2.08 2.38
10 3.95 1.26 1.25 1.30 1.53
11 1.55 0.81 1.14 0.24 0.29
12 3.01 2.20 2.65 3.10 2.46
Table 4.2 Effects of xylocaine on y-axis tremor during movement
Data are presented for frequency range at 2 -20 Hz and at intervals o f up to 60 minutes after the 
application o f  placebo spray. The value o f  tremor spectrum area have been multiplied by 10 .^ Subjects 
4 and 6 show s high tremor at 0 minutes before the xylocaine spray and decrease tremor after 
xylocaine. Subjects 5 and 9 low tremor at 0 minutes and increase tremor after xylocaine. Subjects 10 
and 11 low tremor but decrease after xylocaine. Subject 3, 7, 8 and 12 low tremor and the changes 
very small and unstable over one hour. However, there is no significant change in characteristic o f  
tremor over 60 minutes P value 0.163. The data were subjected to A NO VA  analysis using General 
Linear M odel.
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Subject No. 0 min 15 min 30 min 45 min 60 min
1 7.46 3.25 3.90 3.71 2.98
2 13.33 10.74 9.77 7.56 13.22
3 14.25 9.68 5.48 4.08 4.95
4 9.04 5.07 4.54 6.22 3.94
5 12.03 5.47 0.78 5.37 4.87
6 6.49 0.99 7.82 13.85 11.01
7 21.26 7.70 10.92 5.61 4.23
8 3.17 2.46 1.75 8.84 3.65
9 2.05 1.77 1.32 1.36 1.19
10 4.36 4.87 4.54 6.05 7.87
11 3.50 4.14 3.31 1.88 1.48
12 5.86 2.28 2.23 2.70 2.41
Table 4.3. Effects of placebo on y-axis tremor during movement
Data are presented for frequency range at 2 -20 Hz and at intervals o f up to 60 minutes after the 
application o f  placebo spray. The values o f  tremor spectrum area have been multiplied by 10 .^ 
Subjects 2, 3, 5 and 7 shows high tremor at 0 minutes before the placebo spray and decrease tremor 
after placebo spray. Subjects’ I, 4 ,9 ,1 1, and 12 low tremors at 0 minutes and reduce tremor after 
placebo spray. Subjects 6 and 10 low  tremor and inerease after placebo spray. Subject 8 low tremor 
and the changes very small and unstable over one hour. However, there is no significant change in 
charaeteristic o f tremor over 60 minutes P value 0 .1 15. The data were subjected to A NO VA  analysis 
using the General Linear M odel.
100
(A)
E ffect o f  x y lo ca in e  on  y -a x is  tr e m o r  d u ring  m o v e m e n t fo r  12 sub jects  at 2-
2 0 H z
25
20
15
10
5
0 m in 15 m in 30  m in 
T im e  (m in u tes )
45  m in 6 0  m in
(B)
25
N 20
15
10
5
0
Effect o f Placebo on y-axis trem or during  m ovem ent for 12 subjects at 2-20H z
0 min 15 min 30 min 45 min 60 min
Tim e (m inutes)
Figures 4.5a, b Effects o f xylocaine and placebo sprays on y-axis tremor during 
movement.
The upper figure (a) shows effect o f  xylocaine spray on y-axis tremor all subjects tremor below 15 
and no changes on tremor except for subjects 4 high tremor at 0 minutes before xylocaine spray and 
big reduction on tremor after xylocaine spray.
The lower figure (B) shows effect o f  placebo spray on y-axis tremor. All subjects tremor below 15 
and no changes on tremor except for subject 7 high above 20 and big reduction on tremor after 
placebo.
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Table 4.2 shows the mean and standard deviations of the Y-axis tremor energy 
during movement in 12 neurologically normal volunteers. Data representing the 
tremor amplitude before and after the application of a placebo (P) or topical 
anaesthetic (TA) spray are presented. The table shows details of tremor in three 
frequency bands: 2-6 Hz, 6-12 Hz, 12-20 Hz and for the whole band 2-20 Hz.
The top panel in table 4.2 shows the mean and standard deviation in Y-axis tremor 
during movement at the start of the two experimental sessions. This is before the 
application of sprays. The values are very similar and the data in table 4.1 shows that 
the differences are not statistically significant after placebo or xylocaine over the 5 
periods of measurement. Figure 4.5 shows graphs of these data. The top panel, 
figure 4.5A, shows the mean Y-axis tremor for the 2-20 Hz band in each condition. 
The lower panel, figure 4.5B, shows bar charts of the mean and standard deviations.
The data were subjected to ANOVA analysis and this showed that in neither case did 
the tremor energy change significantly over the period of the experiment (p = 0.115 
for placebo data, p =0.165 for xylocaine data).
1 0 2
Time
Frequency
Band
Mean
Placebo
SD
Placebo
Mean
Xylocaine
SD
Xylocaine
2-6 Hz 2.62 1.72 2.20 1.64
0 min 6-12 Hz 5.11 3.59 4.15 3.90
12-20 Hz 0.83 0.52 0.73 0.65
2-20 Hz 8.57 5.69 7.09 6.07
15 min 2-6 Hz 1.78 0.99 1.73 1.21
6-12 Hz 2.62 2.03 2.65 2.26
12-20 Hz 0.47 0.30 0.37 0.26
2-20 Hz 4.87 3.11 4.75 3.66
30 min 2-6 Hz 1.74 1.32 1.32 0.89
6-12 Hz 2.45 2.15 1.70 1.36
12-20 Hz 0.50 0.46 0.35 0.30
2-20 Hz 4.70 3.29 3.36 2.33
45 min 2-6 Hz 2.50 1.49 1.70 1.83
6-12 Hz 2.39 2.45 1.74 1.43
12-20 Hz 0.71 0.57 0.96 1.68
2-20 Hz 5.60 3.42 4.39 2.63
60 min 2-6 Hz 1.81 0.91 1.64 1.09
6-12 Hz 2.81 2.85 1.94 2.08
12-20 Hz 0.53 0.52 0.42 0.45
2-20 Hz 5.15 3.73 4.00 2.94
Table 4.4. The mean and standard deviation for placebo and xylocaine spray in y- 
axis tremor spectra for twelve volunteers during hand movement.
Data are presented for four frequency ranges and at intervals o f  up to 60 minutes after the application  
o f the spray. 2-20 Hz after placebo no significant changes over the 5 periods o f  measurements when 
tested with an A N O V A  (P = 0 .115). The changes after xylocaine were also not significant (P = 0.163).
The values o f  the tremor spectrum area have been multiplied by 10  ^to make the values easier to read.
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Figure 4.6. Mean and standard deviation of the y-axis tremor during movement after 
application of either a placebo or a topical anaesthesia spray.
Data is shown for tw elve subjects in a frequency band o f  2-20 Hz. No significant changes over 60  
minutes see legend o f  table 4 .2  for statistics.
Panel (A ) show s the mean values and (B ) show s the means and standard deviations.
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4.4.4. Effects of xylocaine on x-axis tremor during movement
The x-axis tremor (medial / lateral deviation) was recorded from the same volunteers 
at the same time as the y-axis tremor. The mean difference between tremor after the 
placebo and after xylocaine (placebo- xylocaine) was calculated. The summary data 
are shown in table 4.5. The mean difference in tremor is shown in the frequency 
bands 2-6 Hz, 6-12 Hz, 12-20 Hz and 2-20 Hz. The confidence intervals are also 
shown.
The top panel of table 4.5 shows that there are no significant differences between the 
X-axis tremors at the start of the experiment. This agrees well with the data for y-axis 
tremor at the same time as shown in table 4.1.
Like the data presented in table 4.1, the mean differences in x axis tremor are not 
significant in any of the frequency bands at any of the times tested. Whilst the y-axis 
tremor differences were almost always negative, the x-axis tremor differences are all 
negative at 15 minutes after the application of the sprays and all positive after 30 
min. At 45 and 60 minute intervals, the differences are a mixture of positive and 
negative values. In general, the positive values indicate reductions in tremor after 
topical anaesthesia but these are non-significant.
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Time Frequency
Band
Mean
difference
Confidence interval
0 min 2-6 Hz 0.16 -0.14 0.47 ns
6-12 Hz -0.23 -1.34 0.88 ns
12-20 Hz 0.02 -0.13 0.17 ns
2-20 Hz -0.05 -1.61 1.52 ns
15 min 2-6 Hz -0.19 -0.49 0.11 ns
6-12 Hz -0.02 -0.62 0.41 ns
12-20 Hz -0.04 -0.13 0.05 ns
2-20 Hz -0.26 -1.25 0.30 ns
30 min 2-6 Hz 0.03 -0.32 0.38 ns
6-12 Hz 0.09 -0.90 1.08 ns
12-20 Hz 0.002 -0.14 0.14 ns
2-20 Hz 0.12 -1.36 1.60 ns
45 min 2-6 Hz 0.02 -0.31 0.35 ns
6-12 Hz -0.11 -0.50 0.27 ns
12-20 Hz 0.01 -0.10 0.13 ns
2-20 Hz -0.08 -0.91 0.75 ns
60 min 2-6 Hz -0.02 -0.19 0.15 ns
6-12 Hz 0.18 -0.44 0.80 ns
12-20 Hz 0.03 -0.05 0.12 ns
2-20 Hz 0.19 -0.68 1.07 ns
Table 4.5. The mean difference between x-axis tremor spectra (placebo - xylocaine) 
for twelve volunteers.
Data are presented for four frequency ranges and at intervals o f up to 60 minutes after application o f  
the spray. The confidence interval Is also show  for each case. All the intervals contain zero and so it 
can be concluded that no significant difference exists between the application o f  xylocaine and the 
placebo.
The values o f  the tremor spectrum area have been multiplied by 10  ^to make the values easier to read.
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No. Subjects 0 min 15 min 30 min 45 min 60 min
1 3.43 2.32 2.14 1.64 1.64
2 3.29 3.54 2.57 2.36 2.56
3 1.94 1.85 2.15 3.54 5.10
4 10.40 4.64 3.93 3.24 2.55
5 4.10 3.22 6.82 4.71 3.52
6 3.32 2.62 2.18 1.47 2.23
7 2.50 2.73 2.37 3.37 3.50
8 2.15 1.79 1.48 2.09 1.33
9 0.90 1.21 1.23 2.03 1.56
10 1.05 3.41 2.87 3.04 2.91
11 3.86 3.43 2.31 0.37 0.35
12 1.38 1.19 0.87 1.63 1.12
Table 4.6 Effect of xylocaine on x-axis tremor during movement
Data are presented for frequency range at 2 -20 Hz and at intervals o f up to 60 minutes after the 
application o f  xylocaine spray. The values o f  tremor spectrum area have been multiplied by 10 .^ All 
subjects have low tremor energy at 0 minutes except for subject 4. In that case the tremor is reduced 
after TA. Subjects 1 and II show  low  initial tremor which reduces further after TA. Subject 10 show s 
tremor increases after TA. Overall, there is no significant change in the tremor energy over 60 minutes 
(p -  0 .743). The data were subjected to A N O V A  analysis using General Linear M odel.
No.
Subjects 0 min 15 min 30 min 45 min 60 min
1 2.18 1.84 2.47 1.96 1.59
2 3.48 2.61 2.84 5.04 4.09
3 6.12 4.09 9.72 4.17 4.59
4 4.55 2.98 1.49 2.67 2.12
5 5.99 3.43 5.22 2.77 6.33
6 3.11 2.77 1.85 2.43 2.30
7 5.47 2.17 3.32 3.04 1.88
8 1.66 1.35 0.80 1.68 2.55
9 1.21 1.13 0.64 0.59 0.79
10 1.27 1.82 2.08 1.84 2.39
11 1.24 1.27 1.16 1.19 0.92
12 1.48 0.80 0.81 1.12 1.17
Table 4.7. Effect of placebo on x-axis tremor during movement
Data are presented for frequency range at 2-20 Hz and at intervals o f up to 60 minutes after the 
application o f  placebo spray. The value o f  tremor spectrum area have been multiplied by 10 .^ All 
subjects show  low  tremor at 0 minutes before placebo spray.
Subject 1, 9,  11 and 12 show reductions in tremor after placebo. Subjects 10 show s a small inerease 
after placebo. However, there is no significant change in the tremor characteristics over the 60  
minutes (p=0.731). The data were subjected to A N O V A  analysis using the General Linear Model.
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Figures 4.7a, b. Individual x-axis tremor during movement at intervals after the 
application of xylocaine and placebo sprays.
The upper figure (A) shows the effect o f  xylocaine spray on x-axis tremor. The lower figure (B) 
show s the effect o f  placebo spray on x-axis tremor. The magnitude o f the x axis tremor was very low  
in all subjects.
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Table 4.8 shows the mean and standard deviations of the X-axis tremor energy 
during movement in same volunteers. These data were recorded concurrently in the 
same sessions. The structure of the table is similar to 4.4.
The data in the top panel in table 4.8 confirms that the X-axis tremor during 
movement is the same at the start of the two experimental sessions. The lower panels 
show the tremor characteristics at 15 to 60 minutes after the application of the sprays. 
Figure 4.7 shows graphs of these data. The top panel, figure 4.7A, shows the mean 
X-axis tremor for the 2-20 Hz band in each condition. The lower panel, figure 4.7B, 
shows bar charts of the mean and standard deviations. There is no significant change 
in the tremor characteristics over this time. (P = 0.731 for placebo data and P = 0.743 
for xylocaine data).
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Time
Frequency
Band
Mean
P
SD
P
Mean
TA
SD
TA
0 min
2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
0.94
1.83
0.37
3.15
0.49
1.26
0.28
2.03
0.77
2.06
0.35
3.19
0.39
2.03
0.26
2.68
15 min 2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
0.78
1.18
0.23
2.19
0.39
0.65
0.11
1.15
0.97
1.42
0.27
2.66
0.34
0.77
0.15
1.25
30 min 2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
0.85
1.57
0.28
2.70
0.61
1.78
0.27
2.66
0.82
1.48
0.28
2.58
0.30
1.24
0.15
1.68
45 min 2-6 Hz
6-12 Hz 
12-20 Hz 
2-20 Hz
0.86
1.26
0.25
2.37
0.50
0.81
0.16
1.47
0.85
1.37
0.23
2.46
0.31
0.92
0.14
1.36
60 min 2-6 Hz 
6-12 Hz 
12-20 Hz 
2-20 Hz
0.79
1.52
0.25
2.56
0.39
1.44
0.16
1.99
0.81
1.34
0.21
Z36
0.36
0.94
0.13
1.43
Table 4.8. The mean and standard deviation for placebo and topical anaesthesia spray 
in X-axis tremor spectra for twelve volunteers during hand movement.
Data are presented for four frequency ranges and at intervals o f  up to 60 minutes after the application 
o f the spray. The values o f  the tremor spectrum area have been multiplied by 10  ^to make the values 
easier to read.
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Figure 4.8. Mean and standard deviation for placebo and topical anaesthesia.
This shows the mean x-axis tremor in the frequency band 2-20 Hz, during movement for twelve 
subjects. (A ) mean values (B ) mean and standard deviations. No significant change was found over 
60 minutes (p = 0.731 for placebo and p = 0.743 for topical anaesthesia, A NO VA ).
4.5. Discussion
In the previous chapter the effect of topical anaesthesia on physiological tremor of 
the hand at rest was investigated. The results showed no significant differences 
between placebo and xylocaine in nineteen normal subjects. In this chapter the effect 
topical anaesthesia on tremor of hand during movement was investigated in twelve 
normal subjects. The data in tables 4.1 and 4.3 show that there is no significant 
difference between the application of the placebo and 10% xylocaine sprays.
The rationale of these experiments was that resting and movement tremors have 
different origins within the CNS. The tremor during voluntary movements in normal 
persons is much greater than resting physiologically in the same limb (laizzo and 
Pozos, 1992). This phenomenon was found during these experiments. It can be seen 
by comparing figures 3.2 and 4.3. The hope was that topical anaesthesia might have 
an effect, which was easier to identify during the larger amplitude movement tremor, 
particularly if this had a different mechanism of generation. This did not happen and 
it is clear that topical anaesthesia had no clear action on movement tremor.
This study found that tremor during movement was larger than tremor at rest. This 
confirms previous studies which showed that the neuromuscular system generating 
tremor is capable of dramatically increasing the tremor amplitude and decreasing the 
tremor frequency even in normal subjects (Pozos, laizzo and Petry, 1982). It could be 
that during movement, the receptor sensitivity to muscle length or tension changes 
may be triggering the amplitude-modulated EMG activity associated with tremor 
(Pozos et al., 1982).
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Earlier similar studies by Mills and Pozos (1985) investigated the effect of topical 
anaesthesia on tremor during movement at the ankle. They reported a significant and 
sustained reduction in the tremor amplitude for 20-30 minutes after the application of 
4% xylocaine. The previous chapter also discussed results by Pozos and lazzio 
(1992), which showed that topical anaesthesia with 4% xylocaine suppressed 
essential tremor of the hand for 20 - 30 minutes. The paper by Pozos and lazzio 
(1992) is the only study published to date about topical anaesthesia and tremor.
There are other papers about digital nerve block and voluntary movements such as 
precision grip (Fisher, Galea, Brown and Lemon, 2002). In addition, the effect of 
topical anaesthesia of the foot, produced by the application of EMLA cream, on gait 
has been reported (McDonnell and Warden-Flood, 2000).
The data in this study are in conflict with those reported by Pozos, Mills and laizzo, 
(1984) and Mills and Pozos (1985). They found tremor suppression during 
movement of the ankle and this study found no difference between placebo and 
topical anaesthesia during movement at the wrist. The conflicting results could lie in 
the differences of methodology, for example the tremor generation mechanisms may 
be different in the upper and lower limbs. Alternatively, mechanical factors might be 
responsible, for example the muscle masses and dimension will be very different. 
Both experiments tested neurologically normal individuals over similar periods of 
time. Pozos and Mills tested seven volunteers comparing tremor before and after 
topical anaesthesia. They compared a control period with tremor of up to 30 minutes 
after topical anaesthesia. They reported a significant reduction in tremor after topical 
anaesthesia. Four of these volunteers returned later some months later for a second
1 1 3
test with a placebo spray. No significant differences were reported in this second test. 
They did not report how similar the magnitudes of the tremor were on the two tests.
This study tested 12 persons on two occasions and compared the effects of placebo 
and topical anaesthesia over 60 minute intervals. The volunteers were not informed 
as to the nature of the intervention. There was no difference in the tremor after 
application of placebo or topical anaesthetic sprays.
One possibility is that Pozos and Mills found their effect by chance due to short-term 
changes in the tremor amplitude. A second possibility is that tremor changes as a 
result of some sub-conscious change in the volunteers motor activity. Mills and 
Pozos do not state if their volunteers were blinded to the nature of the sprays. Both of 
these factors could be significant since their experiments tested only a small number 
of volunteers over very short periods.
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Chapter 5 
The effect of topical anaesthesia on pathological 
tremors: some case studies
5.1 Introduction
The previous chapters described investigations of the effect of topical anaesthesia on 
physiological tremors at rest and during movement. The volunteers who took part in 
these experiments had no history of neuropathology. The topical anaesthesia had no 
significant effect on resting tremor in normal persons or on the increased tremor 
during voluntary movement. A final question remained: does topical anaesthesia 
affect tremor in pathological cases?
The origins of pathological tremor were discussed in the General Introduction in 
Chapter 1. Pathological tremors have different causes, large amplitudes and different 
frequencies from resting physiological tremors.
There have been two earlier studies of the effect of local anaesthesia of skin on 
pathological tremors. Pozos and laizzo (1992) showed that anaesthesia of flexor and 
extensor forearm muscles of the hand caused a reduction in amplitude on essential 
tremor of the hand. There is an earlier study by Pozos et al., (1984) in which topical 
anaesthesia of the skin of the lower leg and the proximal one half of the foot were 
reported to reduce clonus at the ankle.
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5.2. Aim
The aim of the experiments reported here was to investigate the effects of topical 
anaesthesia of skin on the pathological tremors seen in a series of case studies.
5.3. Methods and materials
Attempts to recruit patients with pathological tremor in Glasgow to the project were 
unsuccessful. The clinicians would not allow access to their patients since they felt 
that their patients were already fully committed to existing drug trials. The clinicians 
at the King Abdul-Aziz University Hospital, Jeddah, K.S.A. were able to provide 
suitable patients for this study. Patient access was allowed after the Neurology 
Clinical Committee had reviewed the research proposal and approved it.
A series of twelve adult patients were seen. Informed consent was obtained from 
each volunteer patient. They were not a carefully selected group. They reflected the 
range of cases available. All twelve volunteers participated in the experiment. Some 
of the twelve volunteers were poorly diagnosed. Some cases were complicated with 
other pathological problems e.g. stroke, cerebral palsy. Some volunteers already had 
prescribed medication, others did not.
Six cases are presented in detail in this thesis. Their clinical details have been given 
in table 1. Three cases were under medication and have a clear diagnosis. The one 
case of Parkinson’s disease was complicated by diabetes and asthma. One volunteer 
was diagnosed with essential tremor and was treated with Primadone. One female 
volunteer, aged sixty years, was difficult to diagnose. Her condition was described as
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‘unknown type of tremor’. In addition, she was hypertensive and diabetic. She was 
prescribed Sinement. The remaining three cases who attended the hospital were not 
fully investigated or diagnosed and not under medication.
Experimental protocol
The design of experiments is described in detail in Chapter 2. The nature of the 
experiment was explained to each volunteer and informed consent was obtained. A 
two-axis accelerometer was attached to the middle finger of their right hand. The 
tremor accelerations were recorded for 60 seconds, digitised and stored on a laptop 
PC. The volunteers were blinded as to whether a xylocaine or placebo spray had been 
applied to the skin of their upper limb over the flexor and extensor muscle groups of 
the forearm. The sequence of placebo or local anaesthetic was randomised by asking 
the volunteer to select a sealed envelope containing the sequence of sprays to be 
applied.
The spectra were calculated for one minute in the manner described in Chapter 2.
The EMG was recorded but has not been presented here because of the pressure of 
time available for the preparation of the thesis.
5.4 Comparative spectra of physiological and pathological tremor at 
rest
Figure 5.1 shows spectra of x and y-axis tremor recorded at the same time in a 
normal volunteer (top pair of spectra) and three specimen pathological tremors: one 
case of essential tremor, one case of an undiagnosed tremor and an example of 
Parkinsonian tremor. In each pair, the left spectrum is for x-axis tremor and the right
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spectrum is for y-axis tremor. The top three pairs of spectra are shown with the same 
scales to allow easy comparison to be made. The bottom pair are shown with vertical 
scales iOOX less sensitive to accommodate the very large tremor amplitude.
It is clear to see the pathological tremors all show much greater tremor energies than 
the normal physiological tremor in the y-axis. The differences are less clear in the x- 
axis tremor. The cases of essential tremor show larger tremor energy in both planes.
The volunteers with essential and undiagnosed tremor have their peak frequencies 
between 8-12 Hz in both axes. The volunteer with Parkinson’s disease has a single 
peak at 4-6 Hz.
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Figure 5.1. The power spectra for x and y-axis tremor in normal and pathological 
cases.
Each spectrum is calculated for 20 seconds o f  tremor at rest and before any application o f  sprays. X- 
axis tremor (medial lateral plane) is on the left o f  each pair and y-axis tremor (flexion extension plane) 
is on the right.
The ordinates show units o f  power in volts’ .
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Table 5.1 shows the summary of experiments performed in the six case studies 
reported in this thesis. The second and third columns show the mean difference in 
tremor after xylocaine and placebo application. Thus a positive value shows that 
tremor after xylocaine was smaller than tremor after placebo application. A value 
close to zero suggests the effects of both applications were similar. A negative value 
shows that tremor after placebo was smaller than after the xylocaine. If xylocaine 
reduces the tremor there should be a majority of positive values in these columns.
The table 5.1 shows data for each patient at the start of the experiment with 0 
minutes as a control and then at times after the application of the spray. The mean 
difference at the start of the experiment is close to zero in cases 2, 4, 5 and 6. Thus 
the tremor magnitude was similar at the start of both experiments. In cases 1 and 3 
the mean differences are large suggesting that their tremor amplitude was different 
on the two days.
In case 1, all subsequent differences are negative in both the x and y- axis (xylocaine 
- placebo). Tremor after xylocaine application must be less than after the placebo. 
However, the size of this difference is variable. The tremor amplitude in this person 
must change significantly with time. This is clear in figure 1, which shows the raw 
recordings.
In case 3, all the differences are positive. Tremor after xylocaine application is 
smaller than after the placebo. The size of the effect is smaller than for case 1. The 
tremor amplitude must change less with time than it does for case 1. For cases 2, 4, 5 
and 6, all the differences are small and close to zero. Their tremor is very stable and 
there is little difference between xylocaine and placebo applications.
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Case
Number
Age Sex Diagnosis Medicine Time Tremor
Y-
difference
Tremor X- 
difference
1 63 M Parkinson,
Diabetic,
Asthmatic.
Sinemet.
Other
medicines
not
recorded
0 min 
15 min 
30 min 
45 min 
60 min
-90.12
-35.07
-140.90
-5.74
-345.74
-12.06
-2.79
-1.26
-0.05
-9.44
2 23 F Essential
tremor
Primidone
Busperone"*'
0 min 
15 min 
30 mill 
45 min 
60 min
0.62
0.35
0.38
0.39
0.53
0.18
0.10
0.11
0.09
0.14
3 60 F
Unknown
tremor.
Hyper­
tensive,
Diabetic.
Sinemet
Other
medicines
not
recorded
0 min 
15 min 
30 min 
45 min 
60 min
3.54
4.52
3.87
3.65
2.64
27.17
9.08
TB3
-6.29
-8.00
4 40 F Unknown
tremor
None 0 min 
15 min 
30 min 
45 min 
60 min
0.11
-0.01
-0.01
-0.01
0.01
0.004
0.001
-0.009
-0.015
-0.003
5 18 M Unknown
tremor
None 0 min 
15 min 
30 min 
45 min 
60 min
-0.07
0.002
-0.01
-0.001
0.002
-0.01
0.02
0.001
0.003
0.002
6 17 F Unknown
tremor
None 0 min 
15 min 
30 min 
45 min 
60 min
-0.02
-0.02
-0.01
-0.01
-0.01
-0.01
0.02
0.01
0.001
0.01
Table 5.1. Clinical details of the six patients whose tremor is described in this 
chapter.
The mean difference in X  and Y -axis tremor between 2 -  20 Hz is shown. This is calculated as 
Xylocaine-Placebo. The values shown have been multiplied by lO f
"''Primidone: first treatment, '"’"Busperone: second treatment in case 2
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5.5 Case studies
5.5.1 Case 1: Parkinson’s disease
Figure 5.2 shows specimen recordings of x and y-axis tremor in this volunteer. The 
amplitude varies with time. It is clear the amplitude of y-axis tremor is much greater 
than that of the x-axis tremor. The upper panel shows tremor 30 minutes after the 
placebo application. The lower panel shows tremor 30 minutes after the xylocaine 
spray.
Figure 5.3 shows the power spectra calculated from these recordings. It can easily be 
seen that the peaks occur at the same frequency of approximately 6 Hz in both y-axis 
and x -ax is spectra. In this case the amplitude of the peak in both the x and y-axis 
spectra are reduced after xylocaine application.
Inspection of the data in table 5.1 shows that this is a much stronger effect than 
would have been seen in the same person at 45 minutes after the start of the 
experiment. It is smaller than the effect at 60-minute intervals.
It is clear that the tremor amplitude changes substantially with time and that these 
changes are much larger than any that might be associated with the application of the 
sprays. In this case no significant effect due to the application of the topical 
anaesthetic can be detected.
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Figure 5.2. Recordings of the hand tremor in a volunteer with Parkinson’s disease.
These were made 30 minutes after the application o f  a placebo (upper trace) and after the application 
o f a spray containing 10% xylocaine (lower trace).
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f I 
metre/seco nd/second.
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Figure 5.3. Power spectra for x and y-axis tremor in case 1 (Parkinson’s disease).
See table 5.1 for details. Top pair o f  spectra is calculated for 60 seconds o f  y-axis tremor recorded 30  
minutes after application o f  a placebo spray (top left) and a xylocaine spray (top right). Lower pair 
show s x-axis tremor at the same time. All axes are drawn to same scale to allow direct comparison o f  
the spectra.
The ordinate show s tremor energy as volts^.
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5.5.2 Case 2: Essential Tremor
Figure 5.4 shows specimen recordings of x and y-axis tremor in this volunteer. It is 
clear the amplitude of tremor changes less with time when compared with the 
Parkinsonian tremor seen in case one. See figure 5.2. In figure 5.4 it can be seen that 
the amplitude of y-axis tremor is not much greater than that of the x-axis tremor.
The upper panel shows tremor 30 minutes after the placebo application. The lower 
panel shows tremor 30 minutes after the xylocaine spray. It can be seen visually that 
there is little effect.
Figure 5.5 shows the power spectra calculated from these recordings. The y and x- 
axis spectra show peaks at the same frequency of approximately 10 Hz. In this case 
the amplitude of the peak is similar after the xylocaine and placebo application. 
Inspection of the data in table 5.1 shows that there is very little difference between 
the tremor amplitude recorded after application of either the xylocaine or the placebo 
spray.
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Figure 5.4. Recordings o f hand tremor at rest for in this volunteer with essential 
tremor.
The recordings were made 30 minutes after the application o f  a placebo spray (A  upper panel) or 30 
minutes after a xylocaine spray (B lower panel).
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f  1
metre/second/second.
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Figure 5.5. The spectra for x and y-axis tremors in case 2.
This person had essential tremor. See table 5 .1 for details. The top pair o f spectra is calculated for 60  
seconds o f  y-axis tremor (flexion extension plane) at 30 minutes after application o f  a placebo spray 
(top left) and a xylocaine spray (top right). The lower pair o f  spectra show x-axis tremor (medial 
lateral plane).
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5.5.3 Case 3: Tremor of unknown origin
Figure 5.6 shows specimen recordings of y and x-axis tremor in this volunteer. The 
volunteer was under medication (Sinemet). The volunteer notes feeling that the drug 
had no effect on his condition. However, the medication was taken at night and the 
experiment was the following morning. The upper panel shows tremor 30 minutes 
after the application of the placebo. The lower panel shows tremor 30 minutes after 
the xylocaine spray.
The tremor amplitude varies with time and is similar to that seen in case 1 
(Parkinson’s disease). It is clear the amplitude of x-axis tremor is bigger than y-axis 
tremor in both examples. The amplitude of x-axis tremor after xylocaine application 
is bigger than after application of the placebo. The amplitude of the y-axis tremor is 
not much different from x-axis in table 5.1 at 30-minute intervals.
Figure 5.7 shows the power spectra calculated from these recordings. It can easily be 
seen that in both y-axis and x-axis spectra the peaks occur at the same frequency of 
approximately 5 Hz. The peaks are at similar frequencies as in case one (Parkinson’s 
disease). In addition, both case 1 and 3 have been prescribed Sinement. Case 3 
probably has Parkinson’s disease.
The amplitude of the peak in the tremor spectrum increases after xylocaine 
application in the y and x-axis.
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Figure 5.6. Recordings of hand tremor at rest for in this volunteer with an unknown 
tremor.
The recordings were made 30 minutes after the application o f a placebo spray (A  upper panel) or 30 
minutes after a xylocaine spray (B lower panel).
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f 1
metre/second/second.
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Figure 5.7. Power spectra for x and y tremor in case 3 (unknown tremor).
See table 5 . 1 for details. Top pair o f spectra area calculated for 60 seconds o f  y-axis tremor at 30  
minute intervals after the application o f a placebo spray (top left) and a xylocaine spray (top right). 
The lower pair o f spectra show x-axis tremor.
The ordinates show power in volts^.
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5.5.4 Case 4: Tremor of unknown origin
Figure 5.8 shows specimen recordings of the y and x-axis tremor in this volunteer. 
The upper panel shows tremor 30 minutes after the application of the placebo. The 
lower panel shows tremor 30 minutes after the xylocaine spray. It is clear the 
amplitude of y-axis tremor is much greater than that of the x-axis tremor.
Figure 5.9 shows the tremor spectra calculated from these recording. It can easily be 
seen that the peaks occur at the same frequency of approximately 8-10 Hz in both x 
and y spectra. In this case the amplitude of the peaks in the y-axis tremor are similar 
after xylocaine and placebo applications. The peak frequency of the x-axis tremor is 
also at 8-10 Hz and its amplitude is reduced after xylocaine. Inspection of the data in 
table 5.1 shows that this is a very small effect.
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Figure 5.8 Recordings of hand tremor at rest for in a volunteer with an unknown 
tremor.
The recordings were made 30 minutes after application o f a placebo spray (A upper panel) or 30 
minutes after a xylocaine spray (B lower panel).
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f 1 
m etre/seco nd/seco nd.
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Figure 5.9. Spectra for x and y tremor in case 4 (unknown tremor).
See table 1 for clinical details. The top pair o f spectra is calculated for 60 seconds o f y-axis tremor 30  
minutes after the application o f  a placebo spray (top left) and a xylocaine spray (top right). The lower 
pair o f spectra show x-axis tremor.
The ordinates show power in volts'.
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5.5.5 Case 5: Tremor of unknown origin
This volunteer had no contractures or rigidity. The volunteer reported that his tremor 
started when he was 17 years old and in high school. The tremor was most obvious 
when he performed experimental tasks in the laboratory. In addition, his further 
diagnosis was complicated by his refusal to cooperate with clinical EMG studies.
Figure 5.10 shows specimen recordings of x and y-axis tremor in this volunteer. It 
shows almost no tremor at all during recording. The upper panel shows tremor 30 
minutes after the application of a placebo spray. The lower panel shows tremor 30 
minutes after the xylocaine spray. The amplitude of y and x-axis tremor is small and 
stable with time in both axes.
Figure 5.11 shows the tremor spectra calculated from these recordings. The y-axis 
tremor has a clear peak at 10 Hz, which is smaller after xylocaine application than it 
is after the placebo. The magnitude of the x-axis tremor is very small in both 
conditions.
The peak of the y-axis spectra after the placebo lies in the range 8-12 Hz. The tremor 
could be classified as physiological, essential, enhanced physiological or 
psychological tremor. There was a clear reduction in the amplitude of the y-axis 
tremor 30 minutes after the application of xylocaine. The data in table 5.1 shows that 
this effect was not consistent in other measurements. The position of the peak 
frequency was not changes. It is possible that this patient displayed psychogenic 
tremor, which was not elicited by the experimental conditions.
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Figure 5.10 Recordings of hand tremor at rest in a volunteer with an unknown 
tremor.
The recordings were made 30 minutes after application o f a placebo spray (A upper panel) or 30 
minutes after a xylocaine spray (B lower panel).
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f 1
metre/second/second.
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Figure 5.11. This shows spectra for x and y tremor in case 5 (unknown tremor).
See table 1 for clinical details. The top pair o f  spectra is calculated for 60 seconds o f  y-axis tremor 30  
minutes after application o f a placebo spray (top left) and a xylocaine spray (top right). The Lower 
pair o f spectra show x-axis tremor.
The ordinates show power in volts".
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5.5.6 Case 6: Unknown tremor
Figure 5.12 shows specimen recordings of x and y-axis tremor in this volunteer. The 
upper panel shows tremor 30 minutes after the application of a placebo. The lower 
panel shows tremor 30 minutes after the xylocaine spray. The amplitude of both the x 
and y-axis tremor is greater after the placebo than after the xylocaine.
Figure 5.13 shows the tremor spectra calculated from these recordings. It can easily 
be seen that y-axis tremor after xylocaine is bigger than y-axis after the placebo. The 
peaks in the x and y spectra occur at the same frequency, in the range 6-10 Hz. In 
this case the amplitude of the peak increases after xylocaine application. Inspection 
of the data in table 5.1 shows that this small effect would also have been present in 
the same person at 45 and 60 minute intervals after the application of the sprays.
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Figure 5.12. Data recording hand tremor of an unknown type at two visits.
The recordings were made 30 minutes after application o f a placebo spray (A upper panel) or 30 
minutes after a xylocaine spray (B lower panel).
The accelerometer calibration for both channels was 80 millivolts equal to an acceleration o f 1
m etre/second/second.
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Figure 5.13. Spectra for x and y tremor in case 6 (unknown tremor).
See table I for clinical details. The top pair o f spectra is calculated for 60 seconds o f y-axis tremor 30 
minutes after application o f a placebo spray (top left) and a xylocaine spray (top right). The lower pair 
o f spectra show x-axis tremor.
The ordinates show power in volts^.
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5.6. Discussion
Chapters 3 and 4 described investigations of the effect of topical anaesthesia on 
tremor in the hands of normal subjects at rest during voluntary movements of the 
wrist. Briefly, the results showed no significant difference between the tremors after 
topical anaesthesia or placebo. There was no evidence of tremor reduction after 
application of xylocaine. This chapter describes an investigation of the effect of 
topical anaesthesia on hand tremor in six cases of pathological tremor. Again, no 
evidence of reduction in pathological tremors was found.
Pathological tremors may occur as isolated movement disorders, such as essential 
tremor. Tremor may also be present as a manifestation of Parkinson’s disease, 
cerebellar disease or other movement disorders. Although the amplitude of tremor 
often varies, the frequency is usually relatively constant for the affected individual. 
This may be seen, for example, in Case 1, (Parkinson’s disease, figure 5.3) where the 
tremor frequency had a range 4-6 Hz. In case 2 (essential tremor, figure 5.5) the 
tremor frequencies had a range of 8-12 Hz.
Different pathological tremors appear likely to arise through a variety of different 
mechanisms (McAuley and Marsden, 2000). Tremors may be divided in to discrete 
categories according to their frequency and it is possible that tremors of similar 
frequency may have similar modes of generation (McAuley and Marsden, 2000).
The pathological cases presented here do not cover the whole range of pathologies. 
They reflect a sample of the cases seen in one clinical unit. They do contain example 
of more than one type of pathology. There are diagnosed examples of Parkinsonism
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(case 1) and essential tremor (case 2). Case 5 is probably psychogenic tremor. Case 3 
is possibly a second example of Parkinsonism. They are two or more examples of 
undiagnosed tremors. However, the data that presented in this study found no 
significant difference in the tremors after topical anaesthesia or after placebo 
application. Whatever the mechanism generating the tremor in these pathological 
cases, it did not change its behaviour after topical anaesthesia of the skin.
The results in this study are in conflict with those of Pozos and laizzo (1992). They 
reported a significant suppression of the amplitude of essential tremor of the hand 
after topical anaesthesia with 4% xylocaine in six cases. The results in this chapter 
are consistent with those in Chapters 3 and 4 i.e. that topical anaesthesia is 
indistinguishable from placebo effects. Pozos and laizzo also reported that in their 
experiments topical anaesthesia reduced resting tremors. The reasons for the 
differences between the results in that paper and the results reported here have 
already been discussed in chapter 3 and 4. In summary, the difference could be due 
to variations in methodology and the selection of criteria of the pathological cases.
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Chapter 6
Effects of topical anaesthesia and placeho on skin
sensations
6.1 Introduction
The previous chapters 3, 4 and 5 described investigations of the effects of topical 
anaesthesia and placebo sprays on postural tremor, tremor during movement and 
pathological tremor. The results show no statistically significant difference in tremor 
following the application of a topical anaesthesia or placebo spray.
These observations raise a final question: is there a difference in the skin sensation 
following application of these sprays? Surprisingly, none of the early studies of the 
effects of topical anaesthesia report any tests of skin sensation (Pozos and laizzo, 
(1992); Pozos et al., (1984); Pozos et ah, (1982).
The aim of these studies to investigate if cutaneous sensation changes after 
application of the topical anaesthetic and placebo sprays.
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6.2 Aims:
The three aims of the experiments reported in this chapter are:
1. To investigate heavy touch, pinprick and light touch sensations before and after 
the application of topical anaesthesia and placebo sprays.
2. To investigate the repeatability of tests light touch sensation.
3. To investigate change in the repeatability of the effects the topical anaesthesia on 
sensation.
6.3 Materials and methods
6.3.1 Subjects
Twenty adult volunteers both male and female were recruited from students and staff 
of Glasgow University. They were all neurologically normal. The experimental 
protocol was approved by the Research Ethics Committee. Informed consent was 
obtained from each volunteer. Each volunteer made two visits to the laboratory. Each 
visit lasted approximately one hour.
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6.3.2 Testing protocol
The nature of the experiment was explained to the subjects. The sequence of 
application of placebo and local anaesthesia was randomised by asking the volunteer 
to select a sealed envelope containing the sequence of sprays.
Subjects were seated with their arm supported on a table. The skin area under 
investigation was shaved. A stamp was use to print an array of 64 spots on the skin 
of the anterior forearm on the medial aspect, 2 cm - 3 cm below the elbow joint. The 
array was 16 mm by 16 mm and the dot spacing are 1.5 mm.
6.3.4 Recording protocol
Subjects were instructed not to look at test area during the testing. Control tests were 
carried out before the application of either spray. Stimuli were applied to each of the 
64 test points. All the results of the test were recorded on data collection sheet. This 
is illustrated in figure 6.1. The tests were repeated every 15 minutes for one hour.
6.3.5 Stimulation techniques
The spots marked on the skin were sequentially stimulated with a fine von Frey 
bristle to test light touch, a stiff bristle to test heavy touch and a pin to test pin prick 
sensation. The reported sensation at each spot was recorded on a results sheet. A 
typical set of responses is illustrated in figure 6.1.
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6.3.6 Spray application
Details of the spray application were described in chapter 2, sections 2.10.
6.3.7 Data analysis
For each volunteer several features of skin sensation were recorded. For each class of 
stimulation, every positive response was recorded at the appropriate point on a grid. 
The total number of positive responses by each subject was calculated for each visit. 
ANOVA tests (Minitab version 14) were used to compare the number of positive 
responses for each type of stimuli over five time periods and two experimental 
sessions. A General Linear Model was used. The significance level was set at P < 
0.05.
6.4 Results
6.4.1 Effects of xylocaine and placebo on cutaneous sensation
All 14 subjects were tested twice on different days to investigate the repeatability of 
sensations repeatability. Each mode of sensation was analysed separately.
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Figure 6.1 A specimen recording sheet for light touch sensation test.
These panels show a typical record o f  light touch sensation in one volunteer. X  indicates a positive 
response to light touch stimulation. Blank cell indicate no response. Each panel show s the result o f  
testing the same points at the specified time after the application o f topical anaesthetic solution.
The volunteer’s response gradually reduces with time.
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6.4.2 Heavy touch sensation after xylocaine or placebo application.
Table 6. la, b shows the number of grid points at which each volunteer reported 
heavy touch sensation. The upper section of the table shows the data recorded after 
application of xylocaine. The lower section shows the responses in the same 
volunteers after application of the placebo spray. In summary, these data show that 
all volunteers were sensitive at all points tested for the hour after application of either 
spray.
6.4.3 Pinprick touch sensation after xylocaine or placebo application
Table 6.2 a, b shows the results of pin prick tests of sensation in the same volunteers. 
The data are presented in a similar way to table 6.1. The results show that for 12 of 
the volunteers, pinprick sensation is present at all points tested after application of 
either spray.
Two volunteers show differences to this pattern. Subject 1 shows very small 
reductions in pinprick sensation 30 minutes after application of xylocaine but no 
change after application of the placebo. Subject 3 shows progressive reduction 
pinprick sensation at 30, 45 and 60 minutes after xylocaine application. This 
volunteer also reported much smaller reductions in sensation after the placebo spray.
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(A )
No. Subjects 0 min 15 min 30 min 45 min 60 min
1 64 64 64 64 64
2 64 64 64 64 64
3 64 64 64 64 64
4 64 64 64 64 64
5 64 64 64 64 64
6 64 64 64 64 64
7 64 64 64 64 64
8 64 64 64 64 64
9 64 64 64 64 64
10 64 64 64 64 64
11 64 64 64 64 64
12 64 64 64 64 64
13 64 64 64 64 64
14 64 64 64 64 64
(B)
No. Subjects 0 min 15 min 30 min 45 min 60 min
1 64 64 64 64 64
2 64 64 64 64 64
3 64 64 64 64 64
4 64 64 64 64 64
5 64 64 64 64 64
6 64 64 64 64 64
7 64 64 64 64 64
8 64 64 64 64 64
9 64 64 64 64 64
10 64 64 64 64 64
11 64 64 64 64 64
12 64 64 64 64 64
13 64 64 64 64 64
14 64 64 64 64 64
Table 6.1 A, B Heavy touch sensation after application of xylocaine and placebo.
Part A shows the number of points at which each volunteer reported heavy touch sensation at intervals 
after the application of xylocaine. Part B shows the number of points at which each volunteer reported 
heavy touch sensation at intervals after the application a placebo spray.
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(A )
No. Subjects 0 min 15 min 30 min 45 min 60 min
1 64 64 57 64 64
2 64 64 64 64 64
3 64 64 55 44 19
4 64 64 64 64 64
5 64 64 64 64 64
6 64 64 64 64 64
7 64 64 64 64 64
8 64 64 64 64 64
9 64 64 64 64 64
10 64 64 64 64 64
11 64 64 64 64 64
12 64 64 64 64 64
13 64 64 64 64 64
14 64 64 64 64 64
(B)
No. Subjects 0 min 15 min 30 min 45 min 60 min
1 64 64 64 64 64
2 64 64 64 64 64
3 64 64 64 60 62
4 64 64 64 64 64
5 64 64 64 64 64
6 64 64 64 64 64
7 64 64 64 64 64
8 64 64 64 64 64
9 64 64 64 64 64
10 64 64 64 64 64
11 64 64 64 64 64
12 64 64 64 64 64
13 64 64 64 64 64
14 64 64 64 64 64
Table 6.2 a, b. Pinprick sensation after application of xylocaine and placebo.
Part A  shows the number o f points at which each volunteer reported pinprick sensation at intervals 
after the application o f  xylocaine. Part B shows the number o f points at which each volunteer reported 
pinprick sensation at intervals after the application o f  a placebo spray.
Subjects 1 and 3 in A  show reductions in sensation after xylocaine application. Subject 3 also showed  
sm all decreases in sensation after placebo application.
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6.4.4 Light touch sensation after xylocaine and placebo application.
Table 6.3 a, b shows the results of tests of light touch sensation in the same group of 
volunteers. The data are presented in a similar way to table 6.1.
The results of these tests are very different from those reported in tables 6.1 and 6.2. 
The mean number of light touch responses was 22 and 24 out of 64 tests before 
application of the sprays on the two days. The results also show big variation in 
number of positive responses between subjects. Some subjects reported few touches 
on both days, for example subjects 11 and 5. In contrast, some subjects report a large 
number of touches on both days, for example subjects 13 and 14.
Table 6.3 also shows the mean and the standard deviations of the number of positive 
responses at each time after application of the spray. The mean number of positive 
responses is lower in each test after application of xylocaine that it is at the 
corresponding time after application of the placebo. However, these differences are 
not statistically significant (ANOVA, P = 0.149)
The mean values do not fully represent the variation in individual response. These 
are illustrated graphically in figure 6.2. It can be seen that some individuals have a 
high initial response rate which persists after application of either spray. Others have 
a low initial response rate which is also little affected by the sprays. Subject 13 was 
very sensitive to light touch and this did not change. Subjects 5, 6 and 7 were 
insensitive to light touch and this did not change after xylocaine application.
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Subject 11 had a low response rate in the initial test but after application of xylocaine 
there was a progressive reduction from the first test at 15 min and this continued for 
the full hour. In contrast, on the other trial, when this volunteer was exposed to the 
placebo spray, the same low initial response rate was also seen but this rose sharply 
during the experiment to reach positive responses to 54 of the 64 stimuli.
Subject 14 was very sensitive and the number of positive responses to light touch 
stimulation was reduced over the hour after application of the xylocaine but was 
unchanged after the application of the placebo.
These different patterns of responses are illustrated in figure 6.3. It shows examples 
of the four types of response observed. Figure 6.3 shows low light touch sensitivity 
not affected by either xylocaine or the placebo, high sensitivity not affected by 
xylocaine or placebo, low initial sensitivity which increased after xylocaine but not 
after the placebo and high initial sensitivity which fell after xylocaine but not after 
the placebo.
In summary there is no significant difference in the light touch sensation after the 
application of topical anaesthetic and placebo (P = 0.781, ANOVA).
(A)
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No. Subjects 0 min 15 min 30 min 45 min 60 min
1 15 11 16 10 19
2 12 9 8 7 10
3 14 14 10 10 8
4 19 17 18 18 16
5 9 8 6 5 4
6 9 6 12 8 8
7 11 10 8 10 10
8 35 17 9 11 7
9 25 11 7 6 24
10 21 11 16 19 29
11 10 7 2 2 5
12 23 16 19 3 7
13 49 35 45 33 55
14 52 22 14 16 7
Average 22 14 14 11 15
St. Dev. 14 8 10 8 14
(B)
No. Subjects 0 min 15 min 30 min 45 min 60 min
1 16 10 8 5 7
2 16 32 13 8 15
3 16 15 8 2 16
4 19 8 4 1 8
5 8 4 0 6 2
6 10 4 1 0 0
7 18 13 13 13 20
8 38 17 28 4 4
9 26 64 49 46 56
10 19 14 26 18 33
11 6 33 36 35 54
12 36 17 38 37 24
13 49 29 29 41 44
14 53 57 60 64 64
Average 24 23 22 20 25
St. Dev 15 19 19 21 22
Table 6.3A, B Light touch sensation after xylocaine and placebo application.
Part A show s the number o f points at which each volunteer reported light touch sensation at intervals 
after the application o f  xylocaine. Part B shows the number o f points at which each volunteer reported 
light touch sensation at intervals after the application o f a placebo spray.
(A)
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Effect o f  xylocaine on light touch skin sensation
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Figure 6.2 A, B Plot o f the individual responses to light touch stimulation after 
application of placebo and xylocaine sprays.
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Figure 6.3. Effects of xylocaine and placebo sprays on light touch sensation.
The diamond sym bols show  data after placebo application. Dark squares show data after xylocaine 
application.
Subjects 5 and 13 show no change in light touch sensation after xylocaine or placebo spray.
Subject 14 shows reduction light touches after xylocaine. Subject 11 shows increase in light touch 
sensation after placebo application.
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Figure 6.4 Mean and standard deviations of the response to light touch stimulation 
before and after application of placebo and xylocaine
The data shows clear no statistically significant changes after application o f the placebo spray (P = 
0.97, ANO VA).
The data shows a gradual reduction in light touch sensation over one hour after xylocaine application. 
This reduction was not statistically significant (P = 0.149 A NO VA).
There is no statistically significant difference between the mean number o f  positive responses to light 
touch stimulation after placebo or xylocaine over the 60 minutes (P= 0 .781, A NO VA ).
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6.5 Repeatability data
The responses of a group of volunteers to repeated testing was investigated in two 
ways. Firstly, the responses to cutaneous stimulation was compared before the 
application of the sprays. These data are extracted from that already presented in 
tables 6.1 to 6.3. The responses to heavy touch and to pinprick stimulation are clear- 
cut. All 14 volunteers responded positively at all sites on all occasions. The data 
shown below in table 6.4 shows the responses of these volunteers to light touch 
stimulation at the beginning of both experiments i.e. before the blind application of 
placebo or xylocaine. It is clear that there are no differences in the response rates. 
This was confirmed by testing with an ANOVA test, (P= 0.470).
Subject Day 1 Day 2
1 15 16
2 12 16
3 14 16
4 19 19
5 9 8
6 9 10
7 11 18
8 35 38
9 25 26
10 21 19
11 10 6
12 23 36
13 49 49
14 52 53
Table 6.4. A comparison of the number of positive responses to light touch 
stimulation at the start of the experiment on 2 days.
The table show s number o f positive responses to light touch stimulation on two days. N o spray was 
applied to the skin. There is no significant difference in the number o f responses between the 2 days 
(P = 0.470, A NO VA ).
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A second set of six volunteer had their light touch sensation twice after application of 
xylocaine. Their data is summarised in table 6.5. Again there is a similarity in the 
results before the application of the spray. This continues at each of the testing times 
after the application of the xylocaine. There was no statistically significant 
differences between their responses on the two days (P = 0.308, ANOVA).
Subject 0 minutes 15 minutes 30 minutes 45 minutes 60 minutes
Day
1
Day
2
Day
1
Day
2
Day
1
Day
2
Day
1
Day
2
Day
1
Day
2
1 10 15 11 11 13 16 17 10 13 19
2 13 12 8 9 14 8 10 7 10 10
3 11 9 8 8 2 6 2 5 1 4
4 21 19 15 17 13 18 15 18 14 16
5 21 14 14 14 10 10 7 10 8 8
6 12 9 21 6 20 12 8 9 12 8
Table 6.5. A comparison of the number of positive responses to light touch 
stimulation after xylocaine application on 2 days.
The data shows similar on sensation on the 2 days. There are not statistically significant differences 
between the two days (P = 0.308, ANO VA ).
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6.6 Discussion
In the previous chapters 3, 4, and 5 the effect of xylocaine on tremor of the hand 
were investigated. The results showed no significant difference between the mean 
tremor amplitudes after application of placebo and xylocaine sprays. In this chapter 
the effects of topical anaesthesia and placebo sprays on light touch, heavy touch and 
pinprick sensation was investigated in 20 subjects.
There were no differences in pin prick of heavy touch sensation in almost all of the 
volunteers. One volunteer reported a reduction in pin prick sensation after xylocaine. 
Their light touch sense shows a similar reduction after xylocaine. However, their 
light touch is also reduced by the application of the placebo. This person’s heavy 
touch sensation was unaffected over the same period.
The results in figure 6.4 show no significant changes in light touch sensation in the 
hour after application of xylocaine (P = 0.149) or placebo sprays (P = 0.97). Neither 
is there any difference between sensation after the two sprays (P = 0.781).
The reproducibility of each of the modes of sensation over two different days is 
clear. The data in table 6.4 shows no significant variation in 14 subjects over 2 days. 
The responses to light touch after stimulation after application of xylocaine is 
similarly consistent, though it was possible only to test six people in this part of the 
study.
These data show almost no variation in the number of positive responses to pin prick 
and heavy touch stimulation between people, between the same person on two days
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and before and after placebo or xylocaine sprays. These senses are simply not 
affected by the application of xylocaine. However, the position is more complicated 
with the responses to light touch stimulation. The mean data shows no significant 
differences after application of xylocaine and placebo. In this aspect, it is like the 
heavy touch and pinprick sensation. However the response rates for light touch 
were much lower than for the other two senses. Some individuals have data which 
are consistent with a differential action of xylocaine and placebo. In figure 6.3 
subject 14, it appears that light touch sensation is unaffected by the placebo spray but 
is sharply reduced by the xylocaine. However, in the same figure it is clear that 
subject 11 reports a sharp increase in light touch responses after the application of 
the placebo and that xylocaine appears to have no action. This raises the question of 
how accurately the volunteers reported their sensations or how many of the reported 
sensations were the product of illusions rather than the result of mechanical 
stimulation of the skin. It is beyond the scope of this discussion to address these 
questions.
In conclusion, these data show no statistically significant difference in light touch, 
heavy touch and pin prick sensation after the application of placebo and xylocaine 
sprays. The results are also consistent with some individuals, like subject 14, 
showing a differential response to placebo and xylocaine. This is the sole example of 
such behaviour and overall it is safe to conclude that the topical anaesthesia does not 
affect cutaneous receptors.
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Chapter 7
General discussion
Tremor is a big problem for many patients since it affects many of daily living 
activity. It is also of interest to scientists and clinicians because its analysis may 
assist differential diagnosis and so help to a clarify the prognosis for the patient and 
identify potential treatments.
A number of scientific techniques have been used to investigate the origins and 
mechanisms of tremor. Most of the approaches assess the dependence of tremor on 
sensory input from the limb, rather than examining directly the central mechanisms 
which generate the tremor. One approach is to investigate the power spectra of 
tremor of the hand with and without loading of the hand by applying additional 
weights. The extra weight changes the mechanical components of tremor in a 
predictable way and leaves the neurological components unaffected (Deuschl et al, 
2001). Other authors have investigated the relationship between tremor, motor unit 
activity and surface EMG with cross correlation and coherence measures (Halliday, 
Conway, Farmer and Rosenberg, 1999). This shows significant changes in the 
characteristics of the tremor with increased inertial loading. The most common 
experimental approach is to calculate some feature of the tremor spectrum. Some 
authors identify the amplitude of the peaks in the tremor spectrum (Gresty and 
Buckwell, 1990). The essential problem with this approach is that the spectrum may 
be complex with several smaller peaks, some of which may be ignored by the 
analysis. Others have analysed the whole tremor signal and calculated the root mean
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square value (Pozos and laizzo, 1992). The difficulty here is that low frequency 
components, below 2 Hz, may reflect changes in limb position rather than changes in 
tremor. Higher frequency components, possibly above 20 Hz, may reflect other non­
tremor features such as the firing of individual motor units (Findley and Koller,
1994). The data analysis in this thesis used a band frequency analysis and studied 
tremors in the following frequency ranges: 2-6 Hz, 6-12 Hz, 12-20 Hz and 2-20 Hz. 
These frequency ranges contain all the tremor frequencies described in the 
classification of tremors in chapter 1. These are listed in figure 1.2 of the General 
Introduction and Literature Review in Chapter 1.
Tremor amplitude is a variable and changes from minute to minute and day-to-day, 
even in the same person (Findley and Koller 1994). This makes the design of 
experiments to record and investigate tremor very difficult. The fluctuations in 
amplitude occur over a time scale of only a few seconds and establishing a baseline 
tremor is difficult. These observations are applicable for resting and action tremor in 
normal individuals. This can be seen in figures 3.1 and 4.2 of this thesis. It is an even 
bigger problem in cases of pathological tremor. Here the amplitude changes may be 
very large, as can be seen in figures 5.1 and 5.2, which show recordings of tremor in 
a case of Parkinson’s disease (Case 1). There is often difficulty in finding a group 
of similar clinical cases and this depends on many factors, not least co-operation of 
the hospital and the physicians. There are also problems with patients who have other 
illnesses and who may have multiple medications, such as P blockers that may also 
affect their tremor. These features are very clearly seen in table 5.1.
Three main experimental aims were identified:
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1. Does topical anaesthesia have an effect on physiological tremor at rest and during 
movements?
2. Does topical anaesthesia have an effect on the surface EMG of flexor and extensor 
groups in the forearm?
3. Does topical anaesthesia have an effect on pathological tremor?
7.1 Postural Tremor
Despite all the experimental difficulties listed before, it is clear that the first two aims 
have been achieved. Topical anaesthesia has the same action as a placebo application 
and the author concludes that it does not affect tremor at rest or during movement. 
This conclusion is based on the data in chapter 3 and 4. The same result is found for 
the six cases of pathological tremor presented in this thesis. The results shown here 
are clear but do not agree with some earlier studies published by Mills and Pozos, 
(1985) and Pozos and laizzo, (1992).
This thesis investigated the effect of topical anaesthesia on hand tremor in 37 
volunteers: 19 normal subjects at rest, 12 normal subjects during movements and 6 
pathological tremors at rest. The author hoped that topical anaesthesia, following the 
application of a 10% solution of xylocaine, would have a strong effect on cutaneous 
receptors and that this would lead to significant reductions in the amplitude of 
tremor. Previous studies by Mills and Pozos, (1985) and Pozos and laizzo, (1992) 
had shown that topical anaesthesia caused reductions in clonus, action tremor of the
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ankle joint in the lower limb and essential tremor on the hand at rest. They used a 4% 
anaesthetic solution.
The experiments described in this thesis show no significant effects and difference 
between topical anaesthesia and placebo on hand tremor at rest and during voluntary 
movement in normal subjects. In addition, there was no significant effect on 
pathological tremor in a series of six case studies. It is possible that the topical 
anaesthesia applied to intact skin might not penetrate the skin in large enough 
quantities to have a desensitising effect. It is difficult to imagine that 4% xylocaine 
solutions produced topical anaesthesia but that a 10% solution did not.
This study tested a much larger number of volunteers than Mills and Pozos. In this 
thesis 19 subjects were studied who had physiological tremor of the hand at rest 
compared to the Mills and Pozos studies in 1985 who investigated only 3 normal 
subjects in the physiological clonus on ankle joint of lower limb. The muscles in the 
forearm are innervated by the cervical nerve roots C5 to C8, while the calf muscles 
are innervated by L4, L5, and SI. Thus there must be substantial differences in the 
central nervous system pathways linking sensory neurones in these areas to the motor 
neurones. There are differences in mechanical features such as muscle length, mass 
and stiffness in the upper and lower limbs. In addition, the characteristics of motor 
units may vary subtly from subject to subject and the proportion of fast and slow 
motor units may also vary (McAuley and Marsden, 2000). It might be that the 
difference in results is due to the small sample sizes or to differences in the pathways 
controlling the upper and lower limbs.
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7.2 Action Tremor
The author had hoped that the increased tremor amplitude during voluntary 
movements in normal volunteers might be affected by topical anaesthesia even 
though the smaller amplitude-resting tremor had not been changed. The increased 
amplitude of tremor during movement is probably caused by sub-tetanic firing and 
fluctuating recruitment of motor neurons that are near the threshold. The motor unit 
firing combines with cardioballistic factors to drive the limb at its natural frequency. 
The fluctuations in force and displacement may exceed the rhythmic components of 
physiological tremor dependent on the conditions under which tremor is measured. 
The effects of topical anaesthesia on hand tremor during movements have not been 
investigated previously.
This thesis investigated the effect of topical anaesthesia on hand tremor during 
movement in 12 normal subjects. Mills and Pozos, (1985) investigated physiological 
action tremor during movement of the ankle joint in 7 subjects. This study found no 
significant difference between tremor after topical anaesthesia or placebo 
application. Mills and Pozos, (1985) did find a significant difference. The difference 
in the results is probably due to the same factors described above.
7.3 Pathological Tremors
Pathological tremors have different origins from physiological tremors and often 
result from lesions within the central nervous system (McAuley and Marsden, 2000). 
Pathological tremors also tend to have much larger amplitudes. Fundamentally the 
same experiment of measuring resting tremor amplitudes after the application of
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xylocaine or a placebo spray was repeated in a series of case studies of pathological 
tremors in the hope that topical anaesthesia might have a greater action than in the 
normal subjects. The result was consistent with those reported in Chapters 3 and 4. 
Topical anaesthesia had no significant effect on the pathological tremors.
In contrast, Pozos and laizzo in 1992 investigated the effect of topical anaesthesia on 
one type of pathological tremor, essential tremor of the hand. Their patients had 
taken Propanolol two hours before the application of the anaesthetic or the placebo. 
Propranaiol is frequently used as a treatment for tremor and the differences attributed 
to the topical anaesthesia might be due to variations in the action of the Propranaiol.
7.4 Conclusions
Tremor mechanisms have been investigated by many authors but the mechanisms 
causing tremors remain unclear. However, the precise mechanisms of tremor 
generation are not so important in this project. The principal question raised in this 
project was: does topical anaesthesia have a significant action on tremor amplitude? 
The long-term aim was to investigate the potential therapeutic use of topical 
anaesthesia in the management of pathological tremors.
The results clearly show that there is no significant action of placebo or topical 
anaesthesia on the magnitude of tremors at rest during movement or in a small 
number of case studies. There is no reason to suppose it offers a potential therapeutic 
treatment.
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7.5 Future plans
Movement disorders cause function disabilities and they are consequences of most 
neurological disorders. Improved motor function in daily living activities is the most 
important goal of rehabilitation programs. The slow, progressive nature of these 
tremor producing neurological diseases presents an obvious need for long-term 
evaluation of tremor. There have been surprisingly few long-term studies of tremor 
and this is one clear topic that requires more study. In this context it may be 
worthwhile to investigate the effect of topical anaesthesia on tremor over longer 
periods and in lai’ge numbers of patients or volunteers.
The tremor patient must have a better quality of life.
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